<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6982783</article-id><article-id pub-id-type="doi">10.3390/molecules25010183</article-id><article-id pub-id-type="publisher-id">molecules-25-00183</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Lignans and Their Derivatives from Plants as Antivirals</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cui</surname><given-names>Qinghua</given-names></name><xref ref-type="aff" rid="af1-molecules-25-00183">1</xref><xref ref-type="aff" rid="af2-molecules-25-00183">2</xref><xref ref-type="aff" rid="af3-molecules-25-00183">3</xref><xref rid="c1-molecules-25-00183" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9172-7824</contrib-id><name><surname>Du</surname><given-names>Ruikun</given-names></name><xref ref-type="aff" rid="af1-molecules-25-00183">1</xref><xref ref-type="aff" rid="af2-molecules-25-00183">2</xref><xref ref-type="aff" rid="af3-molecules-25-00183">3</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Miaomiao</given-names></name><xref ref-type="aff" rid="af1-molecules-25-00183">1</xref></contrib><contrib contrib-type="author"><name><surname>Rong</surname><given-names>Lijun</given-names></name><xref ref-type="aff" rid="af4-molecules-25-00183">4</xref><xref rid="c1-molecules-25-00183" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Barker</surname><given-names>David</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-25-00183"><label>1</label>College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; <email>duzi857@163.com</email> (R.D.); <email>17862972322@163.com</email> (M.L.)</aff><aff id="af2-molecules-25-00183"><label>2</label>Qingdao Academy of Chinese Medicinal Sciences, Shandong University of Traditional Chinese Medicine, Qingdao 266122, China</aff><aff id="af3-molecules-25-00183"><label>3</label>Research Center, Shandong University of Traditional Chinese Medicine, Jinan 250355, China</aff><aff id="af4-molecules-25-00183"><label>4</label>Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA</aff><author-notes><corresp id="c1-molecules-25-00183"><label>*</label>Correspondence: <email>cuiqinghua1122@163.com</email> (Q.C.); <email>lijun@uic.edu</email> (L.R.); Tel.: +86-186-6017-1818 (Q.C.); +1-312-996-0110 (L.R.)</corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2020</year></pub-date><volume>25</volume><issue>1</issue><elocation-id>183</elocation-id><history><date date-type="received"><day>08</day><month>11</month><year>2019</year></date><date date-type="accepted"><day>23</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Lignans are widely produced by various plant species; they are a class of natural products that share structural similarity. They usually contain a core scaffold that is formed by two or more phenylpropanoid units. Lignans possess diverse pharmacological properties, including their antiviral activities that have been reported in recent years. This review discusses the distribution of lignans in nature according to their structural classification, and it provides a comprehensive summary of their antiviral activities. Among them, two types of antiviral lignans&#x02014;podophyllotoxin and bicyclol, which are used to treat venereal warts and chronic hepatitis B (CHB) in clinical, serve as examples of using lignans for antivirals&#x02014;are discussed in some detail. Prospects of lignans in antiviral drug discovery are also discussed.</p></abstract><kwd-group><kwd>lignans</kwd><kwd>antivirals</kwd><kwd>mechanism</kwd><kwd>drug development</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-25-00183"><title>1. Introduction</title><p>Lignans are a large group of naturally occurring compounds that are derived from the shikimic acid biosynthetic pathway [<xref rid="B1-molecules-25-00183" ref-type="bibr">1</xref>]. Structurally, Lignans contain a basic scaffold of two or more phenylpropanoid units [<xref rid="B2-molecules-25-00183" ref-type="bibr">2</xref>], and the monomers forming lignans are cinnamic acid, cinnamyl alcohol, propenyl benzene, and allyl benzene. When the molecular linkage of monomers occurs between positions &#x003b2;-&#x003b2;&#x02032; (also referred to as an 8-8&#x02032;), these compounds are designated as &#x0201c;classical lignans&#x0201d;. In contrast, the compounds are grouped into &#x0201c;neolignans&#x0201d; if the main structural units are coupled in any other way (non &#x003b2;-&#x003b2;&#x02032; linkage). <xref ref-type="fig" rid="molecules-25-00183-f001">Figure 1</xref> shows the monomers and the classification. Neolignans have more varied structures than classical lignans.</p><p>Lignans are widely distributed in the plant kingdom, and they exist in plant roots, rhizomes, stems, leaves, flowers, fruits, seeds, xylem, and resins. Plants, such as the <italic>Lauraceae</italic> family, especially the genera of <italic>Machilus</italic>, <italic>Ocotea</italic>, and <italic>Nectandra</italic> are rich sources of lignans. Additionally, <italic>Annonaceae</italic>, <italic>Orchidaceae</italic>, <italic>Berberidaceae</italic>, and <italic>Schisandraceae</italic> family contain a large number of constituents of lignans and neolignans [<xref rid="B3-molecules-25-00183" ref-type="bibr">3</xref>,<xref rid="B4-molecules-25-00183" ref-type="bibr">4</xref>,<xref rid="B5-molecules-25-00183" ref-type="bibr">5</xref>]. Up to date, lignans are found in over 70 families in plant kingdom, and more than 200 classical lignans and 100 neolignans have been characterized [<xref rid="B6-molecules-25-00183" ref-type="bibr">6</xref>]. They are usually present as dimers, but some of them are trimers or tetramers. Most of the lignans in plants are in a free state, while some of them can combine with glycon and form glycosides and other derivatives.</p><p>With such structural diversity of lignans being discovered, it is not surprising that many attractive pharmacological activities of the lignan family, such as antitumor [<xref rid="B7-molecules-25-00183" ref-type="bibr">7</xref>], antioxidant [<xref rid="B5-molecules-25-00183" ref-type="bibr">5</xref>], antibacterial [<xref rid="B8-molecules-25-00183" ref-type="bibr">8</xref>], immunosuppressive [<xref rid="B9-molecules-25-00183" ref-type="bibr">9</xref>], and antiasthmatic properties [<xref rid="B10-molecules-25-00183" ref-type="bibr">10</xref>] were reported. Pertinent to this review, many lignans have been identified with antiviral activities [<xref rid="B11-molecules-25-00183" ref-type="bibr">11</xref>]. Tubulin binding, reverse transcriptase inhibition, integrase inhibition, and topoisomerase inhibition are included as the reported mechanisms of antiviral activities [<xref rid="B12-molecules-25-00183" ref-type="bibr">12</xref>]. Here, we will highlight the antiviral activities and mechanisms of action (MOA) of different lignans and their derivatives.</p></sec><sec id="sec2-molecules-25-00183"><title>2. Antiviral Effect and MOA</title><p>Lignans display a vast structural diversity due to the numerous potential coupling modes of the phenoxy radicals [<xref rid="B13-molecules-25-00183" ref-type="bibr">13</xref>]. As mentioned above, they can be grouped into two subclasses: classical lignans and neolignans. Next, we will discuss the antiviral lignans and possible MOA, according to different subclasses, and then summarize them in <xref rid="molecules-25-00183-t001" ref-type="table">Table 1</xref> at the end of this section.</p><sec id="sec2dot1-molecules-25-00183"><title>2.1. Classical Lignans</title><p>The classical lignans contain dimeric structures that are formed by a &#x003b2;-&#x003b2;&#x02032;-linkage between two phenyl propane units, some of them with a different degree of oxidation in the side-chain and a different substitution pattern in the aromatic moieties. They can be classified into six major subtypes&#x02014;dibenzylbutanes, dibenzylbutyrolactones, arylnaphthalenes/aryltetralins, substituted tetrahydro-furans, 2,6-diarylfurofurans, and dibenzocyclooctadienes [<xref rid="B6-molecules-25-00183" ref-type="bibr">6</xref>,<xref rid="B14-molecules-25-00183" ref-type="bibr">14</xref>]. <xref ref-type="fig" rid="molecules-25-00183-f002">Figure 2</xref> illustrates the structures and relationships among them.</p><sec id="sec2dot1dot1-molecules-25-00183"><title>2.1.1. Dibenzylbutanes</title><p>Dibenzylbutanes, which are also known as simple lignans, are the simplest classical lignans, which are the only lignan subtype without being cyclized. They are phenylpropane dimers that have a &#x003b2;-&#x003b2;&#x02032; linkage. Dibenzylbutane lignans also show an increased diversity due to multiple possible oxidation states along the butane chain [<xref rid="B15-molecules-25-00183" ref-type="bibr">15</xref>]. Niranthin, nordihydroguaiaretic acid (NDGA), and terameprocol (TMP), are the representative compounds with antiviral activity in this subclass, and <xref ref-type="fig" rid="molecules-25-00183-f003">Figure 3</xref> shows their structures.</p><p>Niranthin. This compound was first isolated from <italic>Phyllanthus niruri Linn</italic>. (family Euphorbiaceae) [<xref rid="B16-molecules-25-00183" ref-type="bibr">16</xref>], which has long been used in folk medicine for liver protection and anti-hepatitis B virus (HBV) in many Asian countries. Ray-L screened 25 compounds from <italic>Phyllanthus</italic> Species in vitro and niranthin showed the best anti-HBsAg activity among them [<xref rid="B12-molecules-25-00183" ref-type="bibr">12</xref>]. When evaluated for the anti-HBV activity in vitro, niranthin was found to significantly decrease the secretion of HBsAg and HBeAg with IC<sub>50</sub> values of 15.6 and 25.1 &#x000b5;M in the human HBV-transfected cell line HepG2.2.15, respectively. In vivo, niranthin treatment of the DHBV-infected ducklings significantly reduced the serum DHBV DNA, HBsAg, HBeAg, ALT, and AST. Mechanistic studies showed that niranthin inhibited not only DHBV DNA replication, but also HBV antigen expression, which suggests that niranthin acts as an anti-HBV agent through at least two or more targets [<xref rid="B16-molecules-25-00183" ref-type="bibr">16</xref>].</p><p>NDGA was isolated from the leaves of <italic>Larrea tridentata</italic> (Zygophyllaceae); the plant was known as creosote bush, which has been traditionally used in folk medicine across different countries and regions for more than 50 different diseases [<xref rid="B17-molecules-25-00183" ref-type="bibr">17</xref>]. It was reported that NDGA exerts beneficial effects on diverse diseases, like cancer, renal damage, Alzheimer&#x02019;s disease, and other neurodegenerative pathologies [<xref rid="B18-molecules-25-00183" ref-type="bibr">18</xref>,<xref rid="B19-molecules-25-00183" ref-type="bibr">19</xref>,<xref rid="B20-molecules-25-00183" ref-type="bibr">20</xref>]. At the molecular level, NDGA is a potent scavenger of reactive oxygen species [<xref rid="B21-molecules-25-00183" ref-type="bibr">21</xref>]. NDGA has been identified to inhibit the replication of the related dengue virus (DENV); MOA showed that it inhibits DENV infection by targeting genome replication and viral assembly [<xref rid="B22-molecules-25-00183" ref-type="bibr">22</xref>]. Moreover, NDGA showed the effect against hepatitis C virus (HCV), West Nile Virus (WNV), and Zika Virus (ZIKV) in vitro [<xref rid="B23-molecules-25-00183" ref-type="bibr">23</xref>,<xref rid="B24-molecules-25-00183" ref-type="bibr">24</xref>]. For influenza A viruses (IAV), NDGA can suppress the replication of IAV and the induction of cytokines, trypsin, and MMP-9, with improved animal survival [<xref rid="B25-molecules-25-00183" ref-type="bibr">25</xref>]. See <xref rid="molecules-25-00183-t001" ref-type="table">Table 1</xref> for more details.</p><p>TMP is the shorter title of tetra-<italic>O</italic>-methyl nordihydroguaiaretic acid. It is a methylated derivative of NDGA and was also initially founded in the resin of the creosote bush [<xref rid="B26-molecules-25-00183" ref-type="bibr">26</xref>]. As the derivative of NDGA, it was tested the antiviral effects against WNV and ZIKV simultaneously with NDGA; the results showed both compounds inhibited the infection of WNV and ZIKA, with good and similar IC<sub>50</sub> values, and MOA was likely by impairing viral replication [<xref rid="B24-molecules-25-00183" ref-type="bibr">24</xref>]. Meanwhile, Pollara showed that TMP inhibits poxvirus growth in vitro by preventing the efficient spread of virus particles from cell to cell [<xref rid="B27-molecules-25-00183" ref-type="bibr">27</xref>]. Additionally, there were some reports regarding the antiviral activity of TMP against herpes simplex virus (HSV) and human immunodeficiency virus (HIV) [<xref rid="B28-molecules-25-00183" ref-type="bibr">28</xref>,<xref rid="B29-molecules-25-00183" ref-type="bibr">29</xref>]. Moreover, it was made into vaginal ointment for women with HPV-linked cervical intraepithelial neoplasia and it showed an excellent safety profile in Phase I/II trials [<xref rid="B30-molecules-25-00183" ref-type="bibr">30</xref>].</p><p>Besides, Xu isolated four new lignans from the aerial parts of <italic>Justicia procumbens</italic> (Acanthaceae) and tested their activity against HIV-1. One of the new secoisolariciresinol dimethylether acetate exhibited anti-HIV-1 activity with an IC<sub>50</sub> of 5.27 &#x000b5;M in vitro [<xref rid="B31-molecules-25-00183" ref-type="bibr">31</xref>].</p></sec><sec id="sec2dot1dot2-molecules-25-00183"><title>2.1.2. Dibenzylbutyrolactones</title><p>Dibenzylbutyrolactones, which are also known as lignans-&#x003b2;-&#x003b2;&#x02032;-lactones(lignanolides), are based on dibenzylbutanes, with 9-9&#x02032;epoxy and C9 carbonyl. Lignanolides are often found in the same plants as theirmonode- hydrogenated or didehydrogenated compounds and corresponding derivatives. The representative compounds with antiviral activities in this subclass are arctigenin (ATG), yatein, and hinokinin (<xref ref-type="fig" rid="molecules-25-00183-f004">Figure 4</xref>).</p><p>ATG was initially isolated from <italic>Arctium lappa</italic> L. (Compositae). So far, the research of antiviral activity has been mainly focused on IAV and HIV. The erythrocyte agglutination test showed that ATG can inhibit the replication of the IAV in vitro, and the inhibition was shown to be 100% with a concentration of 26.8 mM based on hemagglutination titer [<xref rid="B32-molecules-25-00183" ref-type="bibr">32</xref>]. In vivo, ATG can reduce lung index, increase the survival rate of the infected mice, and induce the interferon levels of normal mice, which suggested that mechanistically ATG can induce the production of interferon [<xref rid="B33-molecules-25-00183" ref-type="bibr">33</xref>]. ATG and its glycoside arctiin were also shown to be orally effective, but less than oseltamivir, the results suggested that it is a good choice of the combined arctiin with oseltamivir for IAV in immunocompromised mice that were infected with IAV [<xref rid="B34-molecules-25-00183" ref-type="bibr">34</xref>]. Additionally, ATG strongly inhibited the expression of protein P17 and P24 of the HIV-1 in vitro. MOA showed that it targets reverse transcription [<xref rid="B35-molecules-25-00183" ref-type="bibr">35</xref>]. Studies on the structure-activity relationship (SAR) showed that: (1) the structure of lactones is necessary; and, (2) the number and arrangement of phenolic hydroxyl groups are very important for the activity of lignanolides [<xref rid="B36-molecules-25-00183" ref-type="bibr">36</xref>].</p><p>Yatein was isolated from <italic>Chamaecyparis obtuse</italic> (Cupressaceae). It could significantly suppress HSV-1 replication in HeLa cells without apparent cytotoxicity [<xref rid="B37-molecules-25-00183" ref-type="bibr">37</xref>]. MOA showed that yatein can inhibit HSV-1 alpha gene expression, including the expression of the <italic>ICP0</italic> and <italic>ICP4</italic> genes, by arresting HSV-1 DNA synthesis and structural protein expression in HeLa cells [<xref rid="B38-molecules-25-00183" ref-type="bibr">38</xref>].</p><p>Hinokinin was first isolated from the ether extract of <italic>Chamecyparis obtusa</italic> in 1933, and it was also found in different species of <italic>Phyllanthus</italic> (Euphobiaceae) [<xref rid="B39-molecules-25-00183" ref-type="bibr">39</xref>], <italic>Aristolochia</italic> (Aristolochiaceae) [<xref rid="B40-molecules-25-00183" ref-type="bibr">40</xref>], <italic>Piper</italic> (Piperaceae) [<xref rid="B41-molecules-25-00183" ref-type="bibr">41</xref>], <italic>Virola</italic> (Myristicaceae) [<xref rid="B42-molecules-25-00183" ref-type="bibr">42</xref>], <italic>Linum</italic> (Linaceae) [<xref rid="B43-molecules-25-00183" ref-type="bibr">43</xref>], and so on. The anti-inflammatory, antimicrobial activities, and cytotoxicity of this compound have been extensively studied [<xref rid="B44-molecules-25-00183" ref-type="bibr">44</xref>]. Meanwhile, it showed good antiviral activities against human HBV [<xref rid="B12-molecules-25-00183" ref-type="bibr">12</xref>], HIV [<xref rid="B45-molecules-25-00183" ref-type="bibr">45</xref>], SARS-virus (SARS-CoV) [<xref rid="B46-molecules-25-00183" ref-type="bibr">46</xref>], and human cytomegalovirus (HCMV) [<xref rid="B47-molecules-25-00183" ref-type="bibr">47</xref>]. The defects are all data from in vitro and no in-depth research on MOA.</p></sec><sec id="sec2dot1dot3-molecules-25-00183"><title>2.1.3. Arylnaphthalenes/Aryltetralins</title><p>The relationship between the arylnaphthalene and aryltetralin subclasses is of interest due to their deceptive structural similarities. Both of these compounds are based on dibenzylbutanes and formed by cyclization of six sites in one C6-C3 unit and seven sites in another C6-C3 unit. Their subtle structural difference lies in whether the B ring consists of a benzene ring or a six-membered ring. Arylnaphthalenes are also named benzene tetrahydronaphthalene, which means that the B-ring structure consists of six-membered rings. Aryltetralins are named benzene naphthalene, because the B-ring structure consists of benzene. The representative compounds of arylnaphthalene are diphyllin and 6-deoxyglucose-diphyllin (DGP), and podophyllotoxin represents aryltetralin (<xref ref-type="fig" rid="molecules-25-00183-f005">Figure 5</xref>).</p><p>Diphyllin is a natural component of plants with a naphthalene and one hydroxyl lignans [<xref rid="B48-molecules-25-00183" ref-type="bibr">48</xref>]. It exists in <italic>Haplophyllum alberti-regelii</italic>, <italic>H. bucharicum</italic>, and <italic>H. perforatum</italic> (Rutaceae) [<xref rid="B49-molecules-25-00183" ref-type="bibr">49</xref>]. It showed broad-spectrum antiviral activity as a potent vacuolar ATPase (V-ATPase) inhibitor [<xref rid="B50-molecules-25-00183" ref-type="bibr">50</xref>]. For example, it blocked ZIKV infection in HT1080 cells with an IC<sub>50</sub> of ~0.06 &#x003bc;M [<xref rid="B51-molecules-25-00183" ref-type="bibr">51</xref>]; it also altered the cellular susceptibility to IAV through the inhibition of endosomal acidification, thus interfering with downstream virus replication [<xref rid="B52-molecules-25-00183" ref-type="bibr">52</xref>]. There are more reports regarding the antiviral effect of glycosylated diphyllin.</p><p>DGP, which is also known as patentiflorin A, was first isolated from plant of <italic>Justicia gendarussa</italic> (Acanthaceae) [<xref rid="B53-molecules-25-00183" ref-type="bibr">53</xref>]. As the glycosylated diphyllin, it exhibited anti-ZIKV activity both in vitro and <italic>in vivo</italic>, and it displayed broad-spectrum antiviral activity against other flaviviruses. MOA showed that DGP inhibits ZIKV fusion with cellular membranes and infection by preventing the acidification of endosomal/lysosomal compartments in the target cells [<xref rid="B51-molecules-25-00183" ref-type="bibr">51</xref>]. Besides, it also displays potent activity against a broad spectrum of HIV strains with IC<sub>50</sub> values in the range of 15&#x02013;21 nM [<xref rid="B54-molecules-25-00183" ref-type="bibr">54</xref>]; MOA showed that it acts as a potential inhibitor of HIV-1 reverse transcription [<xref rid="B55-molecules-25-00183" ref-type="bibr">55</xref>].</p><p>Podophyllotoxin is one of the best-characterized lignans which is a type of aryletralin lignan lactone, and it was initially found in <italic>Dysosmae Verspiellis Rhixoma</italic> Et Radix or American mandrake or mayapple (all belong to family Berberidaceae) [<xref rid="B3-molecules-25-00183" ref-type="bibr">3</xref>]. One of the research interests of podophyllotoxin is focused on anti-cancer activities [<xref rid="B56-molecules-25-00183" ref-type="bibr">56</xref>,<xref rid="B57-molecules-25-00183" ref-type="bibr">57</xref>]. Furthermore, it was first cited in 1942 as a topical treatment for venereal warts (Condyloma acuminatum), which is an ailment that is caused by papillomavirus [<xref rid="B11-molecules-25-00183" ref-type="bibr">11</xref>]. The clinical randomized controlled trial data with 45 cases showed that podophyllotoxin 0.5% solution has a beneficial effect on anoenital warts and it is effective and safe for untreated anogenital warts in immunocompetent individuals [<xref rid="B58-molecules-25-00183" ref-type="bibr">58</xref>].</p></sec><sec id="sec2dot1dot4-molecules-25-00183"><title>2.1.4. Substituted Tetrahydrofurans</title><p>Substituted tetrahydrofurans are also designated as monoepoxylignans. It refers to the formation of furan or tetrahydrofuran structures that are based on dibenzylbutanes; the representative compounds are lariciresinol (LA) and the derivatives. <xref ref-type="fig" rid="molecules-25-00183-f006">Figure 6</xref> shows the structures&#x02019; details. There are lots of traditional medicinal plants, such as <italic>Patrinia scabra</italic> Bunge (Caprifoliaceae) [<xref rid="B59-molecules-25-00183" ref-type="bibr">59</xref>], <italic>Stelleropsis tianschanica</italic> (Rutaceae) [<xref rid="B60-molecules-25-00183" ref-type="bibr">60</xref>], and <italic>Rubia philippinensis</italic> (Rubiaceae) [<xref rid="B61-molecules-25-00183" ref-type="bibr">61</xref>] with ingredients of LA and the derivatives. Among them, the plant of <italic>Isatis indigotica</italic> Fort (Cruciferae) was the most studied because of the root.</p><p>The root of <italic>Isatis indigotica</italic> Fort is a very famous antiviral traditional medicine in China and is called <italic>Radix Isatidis</italic> (<italic>Banlangen</italic> in Chinese); during the prevalence of SARS in 2003, the traditional Chinese medicine products containing <italic>Radix Isatidis</italic> were once out of stock in China. So far, lots of derivatives with LA structure were isolated from <italic>Radix Isatidis</italic> and antiviral activities were demonstrated. For example, lariciresinol-4-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranoside was shown to inhibit the IAV-induced pro-inflammatory response [<xref rid="B62-molecules-25-00183" ref-type="bibr">62</xref>]; the underlying defense mechanism against IAV infection is from pharmacological actions on the immune system, signal transduction, cell cycle, and metabolism [<xref rid="B63-molecules-25-00183" ref-type="bibr">63</xref>]; (<italic>7&#x02032;R</italic>,<italic>8S</italic>)-9&#x02032;-lariciresinol-(alpha-methyl)-butanoate showed a low amount of activity to anti-HIV-1 [<xref rid="B64-molecules-25-00183" ref-type="bibr">64</xref>]; Isatindolignanoside A was shown to have antiviral activity against Coxsackievirus B3 (CVB3), with IC<sub>50</sub> and SI values of 25.9 &#x003bc;M and &#x0003e;3.9, respectively [<xref rid="B65-molecules-25-00183" ref-type="bibr">65</xref>]; Clemastanin B (<italic>7S</italic>,<italic>8R</italic>,<italic>8&#x02032;R</italic>-(&#x02212;)-lariciresinol-4,4&#x02032;-bis-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranoside), as the active ingredient of <italic>Radix Isatidis</italic>, it showed to inhibit different subtypes of human IAVs (H1N1, H3N2, and influenza B) [<xref rid="B66-molecules-25-00183" ref-type="bibr">66</xref>].</p></sec><sec id="sec2dot1dot5-molecules-25-00183"><title>2.1.5. 2,6-Diarylfurofurans</title><p>2,6-diarylfurofuran, which is also known as bisepoxylignan, is a lignan with a double tetrahydrofuran ring structure, which is formed by two side chains of phenylpropanoid interlinked to form two epoxy structures. There are a few reports of these compounds on antiviral activities (<xref ref-type="fig" rid="molecules-25-00183-f007">Figure 7</xref>).</p><p>Phillygenin is the major active constituent of <italic>Fructus Forsythiae</italic> (Oleaceae). It can suppresses high glucose-induced lipid accumulation and it has antibacterial and antioxidant activities [<xref rid="B56-molecules-25-00183" ref-type="bibr">56</xref>], and is could also be a potential therapeutic agent for alleviating inflammation [<xref rid="B57-molecules-25-00183" ref-type="bibr">57</xref>]. Antiviral studies show that phillygenin has good protective effects against infections that are caused by IAV; it could reduce inflammation that is caused by IAV in vivo in the meanwhile [<xref rid="B58-molecules-25-00183" ref-type="bibr">58</xref>].</p><p>Sesamin was isolated from the seeds of <italic>Sesamum indicum</italic> (Pedaliaceae). It has anti-inflammatory cytokines in human PBMCs that are induced by H1N1 [<xref rid="B67-molecules-25-00183" ref-type="bibr">67</xref>]. However, there is no report demonstrating its direct anti-influenza activity.</p></sec><sec id="sec2dot1dot6-molecules-25-00183"><title>2.1.6. Dibenzocyclooctenes</title><p>The structure of this subclass of lignans has not only biphenyl structure, but also an eight-membered ring structure synthesized by biphenyl and side chainring. <xref ref-type="fig" rid="molecules-25-00183-f008">Figure 8</xref> shows the structures of dibenzocyclooctadiene and the corresponding compounds. So far, more than 150 lignans have been isolated and identified from more than 60 species of <italic>Schisandraceae</italic> family [<xref rid="B68-molecules-25-00183" ref-type="bibr">68</xref>]. The reason of dibenzocyclooctene lignans are called &#x02018;Schisandra chinensis lignans&#x02019;, even in the professional scientific literature [<xref rid="B69-molecules-25-00183" ref-type="bibr">69</xref>].</p><p><italic>Schisandra Chinensis</italic> (Turcz.) Baill. is the most famous plant in <italic>Schisandraceae</italic> family, and the fruits (called <italic>Fructus Schizandrae</italic>) were widely used as a traditional Chinese medicine for treating hepatitis, myocardial disorders, and hyperlipidemia and neurodegenerative diseases in the countries of East Asia and others [<xref rid="B70-molecules-25-00183" ref-type="bibr">70</xref>,<xref rid="B71-molecules-25-00183" ref-type="bibr">71</xref>,<xref rid="B72-molecules-25-00183" ref-type="bibr">72</xref>]. In this plant, nine major bioactive lignans were identified as dibenzocyclooctenes, they are schisandrol A, schisandrol B, angeloylgomisin H, gomisin G, schisantherin A, schisanhenol, schisandrin A, schisandrin B, and schisandrin C [<xref rid="B73-molecules-25-00183" ref-type="bibr">73</xref>]. In terms of antiviral activities, we have found that schisandrin A inhibits DENV replication via upregulating the antiviral interferon responses through the STAT signaling pathway [<xref rid="B74-molecules-25-00183" ref-type="bibr">74</xref>]. Schisandrin A and schisandrin B exhibited antiviral activity against HIV [<xref rid="B75-molecules-25-00183" ref-type="bibr">75</xref>], and schizandrin C was shown to be the most active compound in protection against liver injury in mice. A derivative of schizandrin C, Bicyclol, has been approved as a hepatoprotectant by the Chinese Food and Drug Administration (CFDA) for the treatment of liver injury in 2004 [<xref rid="B76-molecules-25-00183" ref-type="bibr">76</xref>].</p><p>Bicyclol(4,4&#x02032;-dimethoxy-5,6,5&#x02032;,6&#x02032;-bis(methylenedioxy)-2-hydroxymethyl-2&#x02032;-methoxycarbonyl biphenyl) is an analog of the active component schizandrin C from <italic>Fructus Schiznadrae</italic> [<xref rid="B77-molecules-25-00183" ref-type="bibr">77</xref>], as illustrated in <xref ref-type="fig" rid="molecules-25-00183-f009">Figure 9</xref>. Bicyclol was shown to have activities in vitro and in vivo. Clinical data showed that it could inhibit virus replication in patients that were infected with HBV, and the difference of the response to bicyclol therapy between HBV genotypes B and C was not statistically significant [<xref rid="B78-molecules-25-00183" ref-type="bibr">78</xref>]. Other results showed that bicyclol significantly inhibited HCV replication in vitro and in hepatitis C patients [<xref rid="B79-molecules-25-00183" ref-type="bibr">79</xref>]. Mechanistic studies suggest that anti-hepatitis activity of bicyclol is through the modulation of cytotoxic T lymphocytes [<xref rid="B76-molecules-25-00183" ref-type="bibr">76</xref>], and by up-regulating the host restrictive factor (GLTP) for HCV replication and causing the spontaneous restriction of HCV replication [<xref rid="B79-molecules-25-00183" ref-type="bibr">79</xref>]. Bicyclol is now used to treat the patients with chronic hepatitis B in China [<xref rid="B80-molecules-25-00183" ref-type="bibr">80</xref>].</p><p>Rubrifloralignan A was isolated from another species of <italic>Schisandraceae</italic> family&#x02014;<italic>Schisandra rubriflora</italic>. It can not only inhibits the formation of syncytium induced by HIV-1IIIB and cell death induced by HIV-1, but it also inhibits the replication of HIV. Mechanistically, rubrifloralignan A was shown to inhibit the early stage in HIV-1 replication [<xref rid="B81-molecules-25-00183" ref-type="bibr">81</xref>]. The derivative, (+/&#x02212;)-Gomisin M1, exhibited the most potent anti-HIV activity, with EC<sub>50</sub> and SI values of &#x0003c;0.65 &#x003bc;M and &#x0003e;68, respectively [<xref rid="B82-molecules-25-00183" ref-type="bibr">82</xref>]. Halogenated gomisin J derivatives were shown to be a nonnucleoside inhibitor of HIV type 1 reverse transcriptase [<xref rid="B83-molecules-25-00183" ref-type="bibr">83</xref>].</p></sec></sec><sec id="sec2dot2-molecules-25-00183"><title>2.2. Neolignans</title><p>Neolignans are a class of lignans that do not contain the &#x003b2;-&#x003b2;&#x02032; (also referred to as an 8-8&#x02032;) phenyl-propane linkage that are characteristic of classical lignans. They can be further grouped into different subtypes based on the nature and position of the linkage between the phenylpropane units. In contrast to classical lignans, there are only a few reports on the antiviral activities of neolignans. <xref ref-type="fig" rid="molecules-25-00183-f010">Figure 10</xref> shows the structures of some neolignan compounds.</p><p>1,4-Benzodioxane lignans. This subtype of neolignans has received significant attention through the years due to their good biological activities. One representative is Silymarin flavonolignans, which were isolated from the seeds of <italic>Silybum marianum</italic> [<xref rid="B84-molecules-25-00183" ref-type="bibr">84</xref>] and they are the most commonly consumed herbal products among the HCV-infected patients in western countries [<xref rid="B85-molecules-25-00183" ref-type="bibr">85</xref>]. Besides, they were showed to possess antioxidative, anti-inflammatory, and hepatoprotective activities [<xref rid="B86-molecules-25-00183" ref-type="bibr">86</xref>]. Recent studies have also documented the antiviral activities of silymarin and its derivatives against HCV and other viruses [<xref rid="B87-molecules-25-00183" ref-type="bibr">87</xref>]. Its derivative intravenous silibinin, which was named Legalon<sup>&#x000ae;</sup> SIL, and has been shown to block HCV production and increase anti-inflammatory and anti-proliferative gene expressions without affecting serum albumin levels in the clinical phase [<xref rid="B88-molecules-25-00183" ref-type="bibr">88</xref>]. In addition, it was showed that silymarin inhibited the replication of IAV [<xref rid="B89-molecules-25-00183" ref-type="bibr">89</xref>]. MOA showed that silymarin inhibited the late mRNA synthesis during IAV replication. It was also reported that silymarin inhibited other viruses, such as DENV, Chikungunya virus, Mayaro virus, HIV, and HBV [<xref rid="B86-molecules-25-00183" ref-type="bibr">86</xref>].</p><p>(<italic>7&#x02032;R</italic>,<italic>8&#x02032;S</italic>,<italic>7&#x02033;R</italic>,<italic>8&#x02033;S</italic>)-erythro-strebluslignanol G, a neolignan and also a dimer of strebluslignanols, was isolated from the root of <italic>Streblus asper</italic>. It exhibits significant anti-HBV activities in the secretion of HBsAg and HBeAg, with IC<sub>50</sub> values of 3.67 and 14.67 &#x000b5;M, respectively [<xref rid="B90-molecules-25-00183" ref-type="bibr">90</xref>].</p><p>Secolignans or Cleavage lignans. These neolignans are presumed to be obtained by the pyrolysis, oxidation, and cyclization of arylnaphthalenes [<xref rid="B91-molecules-25-00183" ref-type="bibr">91</xref>]. Most of the reported compounds were isolated from the plants of genus <italic>Peperomia</italic> (Piperaceae) [<xref rid="B92-molecules-25-00183" ref-type="bibr">92</xref>], <italic>Urtica</italic> (Urticaceae) [<xref rid="B93-molecules-25-00183" ref-type="bibr">93</xref>], and <italic>Selaginella</italic> (Selaginellaceae) [<xref rid="B94-molecules-25-00183" ref-type="bibr">94</xref>]. They exhibited anti-tumor [<xref rid="B95-molecules-25-00183" ref-type="bibr">95</xref>], anti-inflammatory [<xref rid="B96-molecules-25-00183" ref-type="bibr">96</xref>], anti-HIV, insect antifeedant [<xref rid="B97-molecules-25-00183" ref-type="bibr">97</xref>], and other pharmacological activities. Two compounds, Peperomins A and B, which were isolated from <italic>Peperomia pellucida</italic> (Piperaceae) [<xref rid="B98-molecules-25-00183" ref-type="bibr">98</xref>], showed moderate inhibitory effects on HIV-1 IIIB growth in C8166 cells, with EC<sub>50</sub> values of around 5 &#x000b5;M. However, it appears that the observed bioactivity was due to cytotoxicity [<xref rid="B99-molecules-25-00183" ref-type="bibr">99</xref>].</p></sec></sec><sec id="sec3-molecules-25-00183"><title>3. Prospects of Lignans and Their Derivatives in Antiviral Development</title><p>Lignans are traditionally defined as a class of secondary metabolites that are derived from the oxidative dimerization of two or more phenylpropanoid units. They boast a vast structural diversity, despite their common biosynthetic origins. It is also well-established that this class of compounds exhibit a range of potent biological activities. Owing to these factors, lignans have proven to be a challenging and desirable synthetic target that have instigated the development of some different synthetic methods, advancing our collective knowledge towards the synthesis of complex and unique structures.</p><p>Virus-related diseases are becoming a more challenging public health concern with increased global travel and emergence of viral resistance to the clinical antiviral drugs. There is an urgent need to develop novel antiviral drugs targeting different viral and host proteins. Lignans, as discussed in this review, have large structural diversity and pharmacological activities, including antivirals. Two types of antiviral lignans&#x02014;podophyllotoxin and bicyclol, which show high potency in the treatment of venereal warts and chronic hepatitis B, respectively&#x02014;serve as good examples of developing lignans for antivirals. However, we believe that the potential of lignans in antivirals needs further exploration in the research and development. As noted above, although many of the classical lignans have been showed to display wide-range antiviral activities, little is known regarding the neolignans, which have more varied structures than classical lignans, with regards to their antiviral activities. These neolignans should be carefully evaluated to assess their activities against different viruses, and it is highly likely that many new antiviral activities will be discovered. Furthermore, action of mechanism studies should be investigated for facilitating the development of lead lignans in antiviral drug discovery.</p></sec></body><back><notes><title>Author Contributions</title><p>Writing&#x02014;Original Draft preparation, Q.C. and M.L.; Writing&#x02014;Review and Editing, L.R., R.D., and Q.C. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This work was supported by (1) The Drug Innovation Major Project (Grant No. 2018ZX09711001); (2) the Key Research and Development Projects of Science and Technology Department of Shandong Province (Grant No. 2017CXGC1309); (3) Shandong Provincial Natural Science Foundation, China (Grant No. ZR2019MH078).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-25-00183"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teponno</surname><given-names>R.B.</given-names></name><name><surname>Kusari</surname><given-names>S.</given-names></name><name><surname>Spiteller</surname><given-names>M.</given-names></name></person-group><article-title>Recent advances in research on lignans and neolignans</article-title><source>Nat. Prod. Rep.</source><year>2016</year><volume>33</volume><fpage>1044</fpage><lpage>1092</lpage><pub-id pub-id-type="doi">10.1039/C6NP00021E</pub-id><?supplied-pmid 27157413?><pub-id pub-id-type="pmid">27157413</pub-id></element-citation></ref><ref id="B2-molecules-25-00183"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayres</surname><given-names>D.C.</given-names></name><name><surname>Loike</surname><given-names>J.D.</given-names></name></person-group><article-title>Lignans. Chemical, Biological and Clinical Properties</article-title><source>Lignans Chem. Biol. Clin. Prop.</source><year>1991</year><volume>100</volume><fpage>1</fpage></element-citation></ref><ref id="B3-molecules-25-00183"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>I.W.</given-names></name></person-group><article-title>Condylomata acuminate</article-title><source>New Orleans Med. Surg. J.</source><year>1942</year><volume>94</volume><fpage>388</fpage><lpage>390</lpage></element-citation></ref><ref id="B4-molecules-25-00183"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X.Q.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>J.X.</given-names></name><name><surname>Zhai</surname><given-names>J.W.</given-names></name><name><surname>Xu</surname><given-names>H.Y.</given-names></name><name><surname>Ni</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>S.S.</given-names></name></person-group><article-title>Chemical Constituents and Biological Activity Profiles on Pleione (Orchidaceae)</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>3195</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24173195</pub-id><?supplied-pmid 31484345?><pub-id pub-id-type="pmid">31484345</pub-id></element-citation></ref><ref id="B5-molecules-25-00183"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>H.L.</given-names></name><name><surname>Liu</surname><given-names>G.T.</given-names></name></person-group><article-title>Antioxidant activity of dibenzocyclooctene lignans isolated from <italic>Schisandraceae</italic></article-title><source>Planta Med.</source><year>1992</year><volume>58</volume><fpage>4</fpage><pub-id pub-id-type="doi">10.1055/s-2006-961473</pub-id><?supplied-pmid 1332091?><pub-id pub-id-type="pmid">1332091</pub-id></element-citation></ref><ref id="B6-molecules-25-00183"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>J.Y.</given-names></name><name><surname>Chen</surname><given-names>S.L.</given-names></name><name><surname>Yang</surname><given-names>M.H.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Sinkkonen</surname><given-names>J.</given-names></name><name><surname>Zou</surname><given-names>K.</given-names></name></person-group><article-title>An update on lignans: Natural products and synthesis</article-title><source>Nat. Prod. Rep.</source><year>2009</year><volume>26</volume><fpage>1251</fpage><lpage>1292</lpage><pub-id pub-id-type="doi">10.1039/b910940d</pub-id><pub-id pub-id-type="pmid">19779640</pub-id></element-citation></ref><ref id="B7-molecules-25-00183"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capilla</surname><given-names>A.S.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>I.</given-names></name><name><surname>Caignard</surname><given-names>D.H.</given-names></name><name><surname>Renard</surname><given-names>P.</given-names></name><name><surname>Pujol</surname><given-names>M.D.</given-names></name></person-group><article-title>Antitumor agents. Synthesis and biological evaluation of new compounds related to podophyllotoxin, containing the 2,3-dihydro-1,4-benzodioxin system</article-title><source>Eur. J. Med. Chem.</source><year>2001</year><volume>36</volume><fpage>11</fpage><pub-id pub-id-type="doi">10.1016/S0223-5234(01)01231-4</pub-id></element-citation></ref><ref id="B8-molecules-25-00183"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawazoe</surname><given-names>K.</given-names></name><name><surname>Yutani</surname><given-names>A.</given-names></name><name><surname>Tamemoto</surname><given-names>K.</given-names></name><name><surname>Yuasa</surname><given-names>S.</given-names></name><name><surname>Shibata</surname><given-names>H.</given-names></name><name><surname>Higuti</surname><given-names>T.</given-names></name><name><surname>Takaishi</surname><given-names>Y.</given-names></name></person-group><article-title>Phenylnaphthalene Compounds from the Subterranean Part of Vitex rotundifolia and Their Antibacterial Activity Against Methicillin-Resistant Staphylococcus aureus</article-title><source>J. Nat. Prod.</source><year>2001</year><volume>64</volume><fpage>588</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1021/np000307b</pub-id><pub-id pub-id-type="pmid">11374949</pub-id></element-citation></ref><ref id="B9-molecules-25-00183"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirano</surname><given-names>T.</given-names></name><name><surname>Wakasugi</surname><given-names>A.</given-names></name><name><surname>Oohara</surname><given-names>M.</given-names></name><name><surname>Oka</surname><given-names>K.</given-names></name><name><surname>Sashida</surname><given-names>Y.</given-names></name></person-group><article-title>Suppression of mitogen-induced proliferation of human peripheral blood lymphocytes by plant lignans</article-title><source>Planta Med.</source><year>1991</year><volume>57</volume><fpage>4</fpage><pub-id pub-id-type="doi">10.1055/s-2006-960110</pub-id></element-citation></ref><ref id="B10-molecules-25-00183"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwasaki</surname><given-names>T.</given-names></name><name><surname>Kondo</surname><given-names>K.</given-names></name><name><surname>Kuroda</surname><given-names>T.</given-names></name><name><surname>Moritani</surname><given-names>Y.</given-names></name><name><surname>Yamagata</surname><given-names>S.</given-names></name><name><surname>Sugiura</surname><given-names>M.</given-names></name><name><surname>Kikkawa</surname><given-names>H.</given-names></name><name><surname>Kaminuma</surname><given-names>O.</given-names></name><name><surname>Ikezawa</surname><given-names>K.</given-names></name></person-group><article-title>Novel selective PDE IV inhibitors as antiasthmatic agents. synthesis and biological activities of a series of 1-aryl-2,3-bis(hydroxymethyl)naphthalene lignans</article-title><source>J. Med. Chem.</source><year>1996</year><volume>39</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.1021/jm9509096</pub-id></element-citation></ref><ref id="B11-molecules-25-00183"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charlton James</surname><given-names>L.</given-names></name></person-group><article-title>Antiviral Activity of Lignans</article-title><source>J. Nat. Prod.</source><year>1998</year><volume>61</volume><fpage>1447</fpage><lpage>1451</lpage><pub-id pub-id-type="doi">10.1021/np980136z</pub-id><?supplied-pmid 9834179?><pub-id pub-id-type="pmid">9834179</pub-id></element-citation></ref><ref id="B12-molecules-25-00183"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>R.L.</given-names></name><name><surname>Huang</surname><given-names>Y.L.</given-names></name><name><surname>Ou</surname><given-names>J.C.</given-names></name><name><surname>Chen</surname><given-names>C.C.</given-names></name><name><surname>Hsu</surname><given-names>F.L.</given-names></name><name><surname>Chang</surname><given-names>C.</given-names></name></person-group><article-title>Screening of 25 compounds isolated from <italic>Phyllanthus</italic> species for anti-human hepatitis B virus in vitro</article-title><source>Phytother Res.</source><year>2003</year><volume>17</volume><fpage>449</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1002/ptr.1167</pub-id><?supplied-pmid 12748977?><pub-id pub-id-type="pmid">12748977</pub-id></element-citation></ref><ref id="B13-molecules-25-00183"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilkington</surname><given-names>L.I.</given-names></name></person-group><article-title>Lignans: A Chemometric Analysis</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>1666</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23071666</pub-id><?supplied-pmid 29987225?><pub-id pub-id-type="pmid">29987225</pub-id></element-citation></ref><ref id="B14-molecules-25-00183"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkman</surname><given-names>L.M.</given-names></name><name><surname>Lampe</surname><given-names>J.W.</given-names></name><name><surname>Campbell</surname><given-names>D.R.</given-names></name><name><surname>Martini</surname><given-names>M.C.</given-names></name><name><surname>Slavin</surname><given-names>J.L.</given-names></name></person-group><article-title>Urinary Lignan and isoflavonoid excretion in men and women consuming vegetable and soy diets</article-title><source>Nutr. Cancer</source><year>1995</year><volume>24</volume><fpage>12</fpage><pub-id pub-id-type="doi">10.1080/01635589509514388</pub-id><?supplied-pmid 7491293?><pub-id pub-id-type="pmid">7491293</pub-id></element-citation></ref><ref id="B15-molecules-25-00183"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffries</surname><given-names>D.E.</given-names></name><name><surname>Lindsley</surname><given-names>C.W.</given-names></name></person-group><article-title>Asymmetric Synthesis of Natural and Unnatural Dibenzylbutane Lignans from a Common Intermediate</article-title><source>J. Org. Chem.</source><year>2019</year><volume>84</volume><fpage>5974</fpage><lpage>5979</lpage><pub-id pub-id-type="doi">10.1021/acs.joc.9b00633</pub-id><?supplied-pmid 31002498?><pub-id pub-id-type="pmid">31002498</pub-id></element-citation></ref><ref id="B16-molecules-25-00183"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Wei</surname><given-names>W.</given-names></name><name><surname>Shi</surname><given-names>K.</given-names></name><name><surname>Cao</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name></person-group><article-title>In Vitro and in vivo anti-hepatitis B virus activities of the lignan niranthin isolated from <italic>Phyllanthus niruri</italic> L.</article-title><source>J. Ethnopharmacol.</source><year>2014</year><volume>155</volume><fpage>1061</fpage><lpage>1067</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.05.064</pub-id><pub-id pub-id-type="pmid">25009077</pub-id></element-citation></ref><ref id="B17-molecules-25-00183"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>D.J.</given-names></name><name><surname>Anderica</surname><given-names>R.A.C.</given-names></name><name><surname>Pedraza</surname><given-names>C.J.</given-names></name></person-group><article-title>Paradoxical cellular effects and biological role of the multifaceted compound nordihydroguaiaretic acid</article-title><source>Arch. Pharm.</source><year>2014</year><volume>347</volume><fpage>685</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1002/ardp.201400159</pub-id></element-citation></ref><ref id="B18-molecules-25-00183"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Z&#x000fa;&#x000f1;iga-Toal&#x000e1;</surname><given-names>A.</given-names></name><name><surname>Zatarain-Barr&#x000f3;n</surname><given-names>Z.L.</given-names></name><name><surname>Hern&#x000e1;ndez-Pando</surname><given-names>R.</given-names></name><name><surname>Negrette-Guzm&#x000e1;n</surname><given-names>M.</given-names></name><name><surname>Huerta-Yepez</surname><given-names>S.</given-names></name><name><surname>Torres</surname><given-names>I.</given-names></name><name><surname>Pinz&#x000f3;n</surname><given-names>E.</given-names></name><name><surname>Tapia</surname><given-names>E.</given-names></name><name><surname>Pedraza-Chaverri</surname><given-names>J.</given-names></name></person-group><article-title>Nordihydroguaiaretic acid induces Nrf2 nuclear translocation in vivo and attenuates renal damage and apoptosis in the ischemia and reperfusion model</article-title><source>Phytomedicine</source><year>2013</year><volume>20</volume><fpage>775</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2013.03.020</pub-id><pub-id pub-id-type="pmid">23643094</pub-id></element-citation></ref><ref id="B19-molecules-25-00183"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>W.</given-names></name><name><surname>Ding</surname><given-names>X.</given-names></name><name><surname>Adrian</surname><given-names>T.</given-names></name></person-group><article-title>The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2002</year><volume>296</volume><fpage>942</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1016/S0006-291X(02)02014-4</pub-id><pub-id pub-id-type="pmid">12200139</pub-id></element-citation></ref><ref id="B20-molecules-25-00183"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzanero</surname><given-names>S.</given-names></name><name><surname>Santro</surname><given-names>T.</given-names></name><name><surname>Arumugam</surname><given-names>T.V.</given-names></name></person-group><article-title>Neuronal oxidative stress in acute ischemic stroke: Sources and contribution to cell injury</article-title><source>Neurochem. Int.</source><year>2013</year><volume>62</volume><fpage>712</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2012.11.009</pub-id><pub-id pub-id-type="pmid">23201332</pub-id></element-citation></ref><ref id="B21-molecules-25-00183"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Floriano-Sanchez</surname><given-names>E.</given-names></name><name><surname>Villanueva</surname><given-names>C.</given-names></name><name><surname>Medina-Campos</surname><given-names>O.N.</given-names></name><name><surname>Rocha</surname><given-names>D.</given-names></name><name><surname>S&#x000e1;nchez-Gonz&#x000e1;lez</surname><given-names>D.J.</given-names></name><name><surname>C&#x000e1;rdenas-Rodr&#x000ed;guez</surname><given-names>N.</given-names></name><name><surname>Pedraza-Chaverr&#x000ed;</surname><given-names>J.</given-names></name></person-group><article-title>Nordihydroguaiaretic acid is a potent in vitro scavenger of peroxynitrite, singlet oxygen, hydroxyl radical, superoxide anion and hypochlorous acid and prevents in vivo ozone-induced tyrosine nitration in lungs</article-title><source>Free Radic Res.</source><year>2006</year><volume>40</volume><fpage>523</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1080/10715760500419365</pub-id><?supplied-pmid 16551579?><pub-id pub-id-type="pmid">16551579</pub-id></element-citation></ref><ref id="B22-molecules-25-00183"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soto</surname><given-names>A.R.</given-names></name><name><surname>Bautista</surname><given-names>C.P.</given-names></name><name><surname>Syed</surname><given-names>G.H.</given-names></name><name><surname>Siddiqui</surname><given-names>A.</given-names></name><name><surname>Del Angel</surname><given-names>R.M.</given-names></name></person-group><article-title>Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus</article-title><source>Antivir. Res.</source><year>2014</year><volume>109</volume><fpage>132</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2014.07.002</pub-id><?supplied-pmid 25017471?><pub-id pub-id-type="pmid">25017471</pub-id></element-citation></ref><ref id="B23-molecules-25-00183"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syed</surname><given-names>G.H.</given-names></name><name><surname>Siddiqui</surname><given-names>A.</given-names></name></person-group><article-title>Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus</article-title><source>Hepatology</source><year>2011</year><volume>54</volume><fpage>1936</fpage><lpage>1946</lpage><pub-id pub-id-type="doi">10.1002/hep.24619</pub-id><?supplied-pmid 21858850?><pub-id pub-id-type="pmid">21858850</pub-id></element-citation></ref><ref id="B24-molecules-25-00183"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merino-Ramos</surname><given-names>T.</given-names></name><name><surname>de Oya</surname><given-names>N.J.</given-names></name><name><surname>Saiz</surname><given-names>J.-C.</given-names></name><name><surname>Mart&#x000ed;n-Acebes</surname><given-names>M.A.</given-names></name></person-group><article-title>Antiviral Activity of Nordihydroguaiaretic Acid and Its Derivative Tetra-<italic>O</italic>-Methyl Nordihydroguaiaretic Acid against West Nile Virus and Zika Virus</article-title><source>Antimicrob. Agents Chemother.</source><year>2017</year><fpage>61</fpage><pub-id pub-id-type="doi">10.1128/AAC.00376-17</pub-id></element-citation></ref><ref id="B25-molecules-25-00183"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Le</surname><given-names>T.Q.</given-names></name><name><surname>Kurihara</surname><given-names>N.</given-names></name><name><surname>Chida</surname><given-names>J.</given-names></name><name><surname>Cisse</surname><given-names>Y.</given-names></name><name><surname>Yano</surname><given-names>M.</given-names></name><name><surname>Kido</surname><given-names>H.</given-names></name></person-group><article-title>Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza</article-title><source>J. Infect. Dis.</source><year>2010</year><volume>202</volume><fpage>991</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1086/656044</pub-id><pub-id pub-id-type="pmid">20731583</pub-id></element-citation></ref><ref id="B26-molecules-25-00183"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyegunwa</surname><given-names>A.O.</given-names></name><name><surname>Sikes</surname><given-names>M.L.</given-names></name><name><surname>Wilson</surname><given-names>J.R.</given-names></name><name><surname>Scholle</surname><given-names>F.</given-names></name><name><surname>Laster</surname><given-names>S.M.</given-names></name></person-group><article-title>Tetra-<italic>O</italic>-methyl nordihydroguaiaretic acid (Terameprocol) inhibits the NF-kappaB-dependent transcription of TNF-alpha and MCP-1/CCL2 genes by preventing RelA from binding its cognate sites on DNA</article-title><source>J. Inflamm.</source><year>2010</year><volume>7</volume><fpage>59</fpage><pub-id pub-id-type="doi">10.1186/1476-9255-7-59</pub-id></element-citation></ref><ref id="B27-molecules-25-00183"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollara</surname><given-names>J.J.</given-names></name><name><surname>Laster</surname><given-names>S.M.</given-names></name><name><surname>Petty</surname><given-names>I.T.</given-names></name></person-group><article-title>Inhibition of poxvirus growth by Terameprocol, a methylated derivative of nordihydroguaiaretic acid</article-title><source>Antivir. Res.</source><year>2010</year><volume>88</volume><fpage>287</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2010.09.017</pub-id><pub-id pub-id-type="pmid">20888364</pub-id></element-citation></ref><ref id="B28-molecules-25-00183"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Teng</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>J.N.</given-names></name><name><surname>Park</surname><given-names>R.</given-names></name><name><surname>Mold</surname><given-names>D.E.</given-names></name><name><surname>Gnabre</surname><given-names>J.</given-names></name><name><surname>Hwu</surname><given-names>J.R.</given-names></name><name><surname>Tseng</surname><given-names>W.N.</given-names></name><name><surname>Huang</surname><given-names>R.C.C.</given-names></name></person-group><article-title>Antiviral Activities of Methylated Nordihydroguaiaretic Acids. 2. Targeting Herpes Simplex Virus Replication by the Mutation Insensitive Transcription Inhibitor Tetra-<italic>O</italic>-methyl-NDGA</article-title><source>J. Med. Chem.</source><year>1998</year><volume>41</volume><fpage>3001</fpage><lpage>3007</lpage><pub-id pub-id-type="doi">10.1021/jm980182w</pub-id><pub-id pub-id-type="pmid">9685239</pub-id></element-citation></ref><ref id="B29-molecules-25-00183"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gnabre</surname><given-names>J.N.</given-names></name><name><surname>Brady</surname><given-names>J.N.</given-names></name><name><surname>Clanton</surname><given-names>D.J.</given-names></name><name><surname>Ito</surname><given-names>Y.</given-names></name><name><surname>Dittmer</surname><given-names>J.</given-names></name><name><surname>Bates</surname><given-names>R.B.</given-names></name><name><surname>Huang</surname><given-names>R.C.</given-names></name></person-group><article-title>Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1995</year><volume>92</volume><fpage>11239</fpage><lpage>11243</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.24.11239</pub-id><pub-id pub-id-type="pmid">7479972</pub-id></element-citation></ref><ref id="B30-molecules-25-00183"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khanna</surname><given-names>N.</given-names></name><name><surname>Dalby</surname><given-names>R.</given-names></name><name><surname>Tan</surname><given-names>M.</given-names></name><name><surname>Arnold</surname><given-names>S.</given-names></name><name><surname>Stern</surname><given-names>J.</given-names></name><name><surname>Frazer</surname><given-names>N.</given-names></name></person-group><article-title>Phase I/II clinical safety studies of terameprocol vaginal ointment</article-title><source>Gynecol. Oncol.</source><year>2007</year><volume>107</volume><fpage>554</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2007.08.074</pub-id><pub-id pub-id-type="pmid">17905420</pub-id></element-citation></ref><ref id="B31-molecules-25-00183"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Ku</surname><given-names>C.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Cheng</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>K.-L.</given-names></name><name><surname>Rong</surname><given-names>L.-J.</given-names></name><name><surname>Zhang</surname><given-names>H.-J.</given-names></name></person-group><article-title>Anti-HIV lignans from <italic>Justicia procumbens</italic></article-title><source>Chin. J. Nat. Med.</source><year>2019</year><volume>17</volume><fpage>945</fpage><lpage>952</lpage><pub-id pub-id-type="doi">10.1016/S1875-5364(19)30117-7</pub-id><pub-id pub-id-type="pmid">31882050</pub-id></element-citation></ref><ref id="B32-molecules-25-00183"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Kang</surname><given-names>T.G.</given-names></name></person-group><article-title>Activity of in vitro anti-influenza virus of arctigenin</article-title><source>Chin. Herb. Med.</source><year>2002</year><volume>33</volume><fpage>724</fpage><lpage>725</lpage></element-citation></ref><ref id="B33-molecules-25-00183"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>N.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name></person-group><article-title>Antiviral effect of Arctigenin Compound on Influenza Virus</article-title><source>Tradit. Chin. Drug Res. Clin. Pharmacol.</source><year>2008</year><volume>19</volume><fpage>4</fpage></element-citation></ref><ref id="B34-molecules-25-00183"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>K.</given-names></name><name><surname>Narutaki</surname><given-names>K.</given-names></name><name><surname>Nagaoka</surname><given-names>Y.</given-names></name><name><surname>Hayashi</surname><given-names>T.</given-names></name><name><surname>Uesato</surname><given-names>S.</given-names></name></person-group><article-title>Therapeutic Effect of Arctiin and Arctigenin in Immunocompetent and Immunocompromised Mice Infected with Influenza A Virus</article-title><source>Biol. Pharm. Bull.</source><year>2010</year><volume>33</volume><fpage>1199</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1248/bpb.33.1199</pub-id><pub-id pub-id-type="pmid">20606313</pub-id></element-citation></ref><ref id="B35-molecules-25-00183"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schr&#x000f6;der</surname><given-names>H.C.</given-names></name><name><surname>Merz</surname><given-names>H.</given-names></name><name><surname>Steffen</surname><given-names>R.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>W.E.</given-names></name><name><surname>Sarin</surname><given-names>P.S.</given-names></name><name><surname>Trumm</surname><given-names>S.</given-names></name><name><surname>Schulz</surname><given-names>J.</given-names></name><name><surname>Eich</surname><given-names>E.</given-names></name></person-group><article-title>Differential in vitro anti-HIV activity of natural lignans</article-title><source>Zeitschrift f&#x000fc;r Naturforschung C</source><year>1990</year><volume>45</volume><fpage>1215</fpage><lpage>1221</lpage></element-citation></ref><ref id="B36-molecules-25-00183"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eich</surname><given-names>E.</given-names></name><name><surname>Pertz</surname><given-names>H.</given-names></name><name><surname>Kaloga</surname><given-names>M.</given-names></name><name><surname>Schulz</surname><given-names>J.</given-names></name><name><surname>Pertz</surname><given-names>H.</given-names></name><name><surname>Eich</surname><given-names>E.</given-names></name><name><surname>Pommier</surname><given-names>Y.</given-names></name></person-group><article-title>(&#x02212;)-Arctigenin as a Lead Structure for Inhibitors of Human Immunodeficiency Virus Type-1 Integrase</article-title><source>J. Med. Chem.</source><year>1996</year><volume>39</volume><fpage>86</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1021/jm950387u</pub-id><pub-id pub-id-type="pmid">8568830</pub-id></element-citation></ref><ref id="B37-molecules-25-00183"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>Y.C.</given-names></name><name><surname>Kuo</surname><given-names>Y.H.</given-names></name><name><surname>Lin</surname><given-names>Y.L.</given-names></name><name><surname>Tsai</surname><given-names>W.J.</given-names></name></person-group><article-title>Yatein from Chamaecyparis obtusa suppresses herpes simplex virus type 1 replication in HeLa cells by interruption the immediate-early gene expression</article-title><source>Antivir. Res.</source><year>2006</year><volume>70</volume><fpage>112</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2006.01.011</pub-id><pub-id pub-id-type="pmid">16540181</pub-id></element-citation></ref><ref id="B38-molecules-25-00183"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Xiong</surname><given-names>Y.</given-names></name><name><surname>Kaushik</surname><given-names>A.C.</given-names></name><name><surname>Muhammad</surname><given-names>J.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Dai</surname><given-names>H.</given-names></name><name><surname>Wei</surname><given-names>D.-Q.</given-names></name></person-group><article-title>New strategy for identifying potential natural HIV-1 non-nucleoside reverse transcriptase inhibitors against drug-resistance: An in silico study</article-title><source>J. Biomol. Struct. Dyn.</source><year>2019</year><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1080/07391102.2019.1656673</pub-id></element-citation></ref><ref id="B39-molecules-25-00183"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>C.</given-names></name><name><surname>Lien</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>K.C.S.C.</given-names></name><name><surname>Li</surname><given-names>S.-S.</given-names></name></person-group><article-title>Lignans from <italic>Phyllanthus urinaria</italic></article-title><source>Phytochemistry</source><year>2003</year><volume>63</volume><fpage>825</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(03)00371-6</pub-id><pub-id pub-id-type="pmid">12877924</pub-id></element-citation></ref><ref id="B40-molecules-25-00183"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>T.</given-names></name></person-group><article-title>Chemical Constituents and Pharmacology of the Aristolochia species</article-title><source>J. Tradit. Complement. Med.</source><year>2012</year><volume>2</volume><fpage>249</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1016/S2225-4110(16)30111-0</pub-id><pub-id pub-id-type="pmid">24716140</pub-id></element-citation></ref><ref id="B41-molecules-25-00183"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gangan</surname><given-names>V.</given-names></name><name><surname>Hussain</surname><given-names>S.S.</given-names></name></person-group><article-title>Alkaloids from Piper hookeri: Revision of NMR assignments by the application of 2D NMR spectroscopy</article-title><source>J. Pharm. Res.</source><year>2011</year><volume>4</volume><fpage>3</fpage></element-citation></ref><ref id="B42-molecules-25-00183"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunomura</surname><given-names>S.</given-names></name><name><surname>Yoshida</surname><given-names>M.</given-names></name></person-group><article-title>Lignans and benzoic acid derivatives from pericarps of Virola multinervia (Myristicaceae)</article-title><source>Biochem. Syst. Ecol.</source><year>2002</year><volume>30</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.1016/S0305-1978(02)00044-3</pub-id></element-citation></ref><ref id="B43-molecules-25-00183"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>T.J.</given-names></name><name><surname>Hemmati</surname><given-names>S.</given-names></name><name><surname>Klaes</surname><given-names>M.</given-names></name><name><surname>Konuklugil</surname><given-names>B.</given-names></name><name><surname>Mohagheghzadeh</surname><given-names>A.</given-names></name><name><surname>Ionkova</surname><given-names>I.</given-names></name><name><surname>Fuss</surname><given-names>E.</given-names></name><name><surname>Alfermann</surname><given-names>A.W.</given-names></name></person-group><article-title>Lignans in flowering aerial parts of Linum species&#x02014;chemodiversity in the light of systematics and phylogeny</article-title><source>Phytochemistry</source><year>2010</year><volume>71</volume><fpage>1714</fpage><lpage>1728</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2010.06.015</pub-id><?supplied-pmid 20655554?><pub-id pub-id-type="pmid">20655554</pub-id></element-citation></ref><ref id="B44-molecules-25-00183"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcotullio</surname><given-names>M.C.</given-names></name><name><surname>Pelosi</surname><given-names>A.</given-names></name><name><surname>Curini</surname><given-names>M.</given-names></name></person-group><article-title>Hinokinin, an emerging bioactive lignan</article-title><source>Molecules</source><year>2014</year><volume>19</volume><fpage>14862</fpage><lpage>14878</lpage><pub-id pub-id-type="doi">10.3390/molecules190914862</pub-id><pub-id pub-id-type="pmid">25232707</pub-id></element-citation></ref><ref id="B45-molecules-25-00183"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>M.-J.</given-names></name><name><surname>Lee</surname><given-names>K.-H.</given-names></name><name><surname>Tsai</surname><given-names>I.-L.</given-names></name><name><surname>Chen</surname><given-names>I.-S.</given-names></name></person-group><article-title>Two new sesquiterpenoids and anti-HIV principles from the root bark of Zanthoxylum ailanthoides</article-title><source>Bioorg. Med. Chem.</source><year>2005</year><volume>13</volume><fpage>5915</fpage><lpage>5920</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2005.07.050</pub-id><pub-id pub-id-type="pmid">16140017</pub-id></element-citation></ref><ref id="B46-molecules-25-00183"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>C.-C.</given-names></name><name><surname>Kuo</surname><given-names>Y.-H.</given-names></name><name><surname>Jan</surname><given-names>J.-T.</given-names></name><name><surname>Liang</surname><given-names>P.-H.</given-names></name><name><surname>Wang</surname><given-names>S.-Y.</given-names></name><name><surname>Liu</surname><given-names>H.-G.</given-names></name><name><surname>Li</surname><given-names>C.-K.</given-names></name><name><surname>Chang</surname><given-names>S.-T.</given-names></name><name><surname>Kuo</surname><given-names>C.-J.</given-names></name><name><surname>Lee</surname><given-names>S.-S.</given-names></name><etal/></person-group><article-title>Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus</article-title><source>J. Med. Chem.</source><year>2007</year><volume>50</volume><fpage>4087</fpage><lpage>4095</lpage><pub-id pub-id-type="doi">10.1021/jm070295s</pub-id><pub-id pub-id-type="pmid">17663539</pub-id></element-citation></ref><ref id="B47-molecules-25-00183"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roz&#x000e1;lia</surname><given-names>P.</given-names></name><name><surname>Abrantes</surname><given-names>M.</given-names></name><name><surname>Serly</surname><given-names>J.</given-names></name><name><surname>Duarte</surname><given-names>N.</given-names></name><name><surname>Molnar</surname><given-names>J.</given-names></name><name><surname>Ferreira</surname><given-names>M.-J.U.</given-names></name></person-group><article-title>Antitumor-promoting Activity of Lignans: Inhibition of Human Cytomegalovirus IE Gene Expression</article-title><source>Anticancer Res.</source><year>2010</year><volume>30</volume><fpage>451</fpage><lpage>454</lpage><pub-id pub-id-type="pmid">20332453</pub-id></element-citation></ref><ref id="B48-molecules-25-00183"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Shen</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Shen</surname><given-names>W.</given-names></name></person-group><article-title>Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells</article-title><source>Oncol. Rep.</source><year>2018</year><volume>39</volume><fpage>921</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.3892/or.2018.6191</pub-id><pub-id pub-id-type="pmid">29328465</pub-id></element-citation></ref><ref id="B49-molecules-25-00183"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nesmelova</surname><given-names>E.F.</given-names></name><name><surname>Razakova</surname><given-names>D.M.</given-names></name><name><surname>Akhmedzhanova</surname><given-names>V.I.</given-names></name><name><surname>Bessonova</surname><given-names>I.A.</given-names></name></person-group><article-title>Diphyllin from <italic>Haplophyllum alberti-regelii</italic>, <italic>H. bucharicum</italic>, and <italic>H. perforatum</italic></article-title><source>Chem. Nat. Compd.</source><year>1983</year><volume>19</volume><fpage>608</fpage><pub-id pub-id-type="doi">10.1007/BF00576100</pub-id></element-citation></ref><ref id="B50-molecules-25-00183"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000f8;rensen</surname><given-names>M.G.</given-names></name><name><surname>Henriksen</surname><given-names>K.</given-names></name><name><surname>Neutzsky-Wulff</surname><given-names>A.V.</given-names></name><name><surname>Dziegiel</surname><given-names>M.H.</given-names></name><name><surname>Karsdal</surname><given-names>M.A.</given-names></name></person-group><article-title>Diphyllin, a Novel and Naturally Potent V-ATPase Inhibitor, Abrogates Acidification of the Osteoclastic Resorption Lacunae and Bone Resorption</article-title><source>J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res.</source><year>2007</year><volume>22</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.1359/jbmr.070613</pub-id></element-citation></ref><ref id="B51-molecules-25-00183"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Lopez</surname><given-names>A.</given-names></name><name><surname>Persaud</surname><given-names>M.</given-names></name><name><surname>Chavez</surname><given-names>M.P.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Rong</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>T.T.</given-names></name><name><surname>Sarafianos</surname><given-names>S.G.</given-names></name><name><surname>Diaz-Griffero</surname><given-names>F.</given-names></name></person-group><article-title>Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virus</article-title><source>EBioMedicine</source><year>2019</year><volume>47</volume><fpage>269</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2019.08.060</pub-id><?supplied-pmid 31501074?><pub-id pub-id-type="pmid">31501074</pub-id></element-citation></ref><ref id="B52-molecules-25-00183"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.-W.</given-names></name><name><surname>Cheng</surname><given-names>J.X.</given-names></name><name><surname>Liu</surname><given-names>M.-T.</given-names></name><name><surname>King</surname><given-names>K.</given-names></name><name><surname>Peng</surname><given-names>J.Y.</given-names></name><name><surname>Zhang</surname><given-names>X.-Q.</given-names></name><name><surname>Wang</surname><given-names>C.-H.</given-names></name><name><surname>Shresta</surname><given-names>S.</given-names></name><name><surname>Schooley</surname><given-names>R.T.</given-names></name><name><surname>Liu</surname><given-names>Y.-T.</given-names></name></person-group><article-title>Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses</article-title><source>Antivir. Res.</source><year>2013</year><volume>99</volume><fpage>371</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2013.06.014</pub-id><?supplied-pmid 23820269?><pub-id pub-id-type="pmid">23820269</pub-id></element-citation></ref><ref id="B53-molecules-25-00183"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Susplugas</surname><given-names>S.</given-names></name><name><surname>Hung</surname><given-names>N.</given-names></name><name><surname>Bignon</surname><given-names>J.</given-names></name><name><surname>Thoison</surname><given-names>O.</given-names></name><name><surname>Kruczynski</surname><given-names>A.</given-names></name><name><surname>S&#x000e9;venet</surname><given-names>T.</given-names></name><name><surname>Gu&#x000e9;ritte</surname><given-names>F.</given-names></name></person-group><article-title>Cytotoxic Arylnaphthalene Lignans from a Vietnamese Acanthaceae. <italic>Justicia patentiflora</italic></article-title><source>J. Nat. Prod.</source><year>2005</year><volume>68</volume><fpage>734</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1021/np050028u</pub-id><?supplied-pmid 15921419?><pub-id pub-id-type="pmid">15921419</pub-id></element-citation></ref><ref id="B54-molecules-25-00183"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.-J.</given-names></name><name><surname>Rumschlag-Booms</surname><given-names>E.</given-names></name><name><surname>Guan</surname><given-names>Y.-F.</given-names></name><name><surname>Liu</surname><given-names>K.-L.</given-names></name><name><surname>Wang</surname><given-names>D.-Y.</given-names></name><name><surname>Li</surname><given-names>W.-F.</given-names></name><name><surname>Nguyen</surname><given-names>V.H.</given-names></name><name><surname>Cuong</surname><given-names>N.M.</given-names></name><name><surname>Soejarto</surname><given-names>D.D.</given-names></name><name><surname>Fong</surname><given-names>H.H.S.</given-names></name></person-group><article-title>Anti-HIV diphyllin glycosides from Justicia gendarussa</article-title><source>Phytochemistry</source><year>2017</year><volume>136</volume><fpage>94</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2017.01.005</pub-id><pub-id pub-id-type="pmid">28110956</pub-id></element-citation></ref><ref id="B55-molecules-25-00183"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.-J.</given-names></name><name><surname>Rumschlag-Booms</surname><given-names>E.</given-names></name><name><surname>Guan</surname><given-names>Y.-F.</given-names></name><name><surname>Wang</surname><given-names>D.-Y.</given-names></name><name><surname>Liu</surname><given-names>K.-L.</given-names></name><name><surname>Li</surname><given-names>W.-F.</given-names></name><name><surname>Nguyen</surname><given-names>V.H.</given-names></name><name><surname>Cuong</surname><given-names>N.M.</given-names></name><name><surname>Soejarto</surname><given-names>D.D.</given-names></name><name><surname>Fong</surname><given-names>H.H.S.</given-names></name></person-group><article-title>Potent Inhibitor of Drug-Resistant HIV-1 Strains Identified from the Medicinal Plant Justicia gendarussa</article-title><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>1798</fpage><lpage>1807</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.7b00004</pub-id><pub-id pub-id-type="pmid">28613071</pub-id></element-citation></ref><ref id="B56-molecules-25-00183"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zalesak</surname><given-names>F.</given-names></name><name><surname>Bon</surname><given-names>D.J.D.</given-names></name><name><surname>Pospisil</surname><given-names>J.</given-names></name></person-group><article-title>Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances</article-title><source>Pharm. Res.</source><year>2019</year><volume>146</volume><fpage>104284</fpage><pub-id pub-id-type="doi">10.1016/j.phrs.2019.104284</pub-id></element-citation></ref><ref id="B57-molecules-25-00183"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsdorf</surname><given-names>W.</given-names></name><name><surname>Seidel</surname><given-names>C.</given-names></name><name><surname>Bokemeyer</surname><given-names>C.</given-names></name><name><surname>Oing</surname><given-names>C.</given-names></name></person-group><article-title>Current pharmacotherapy for testicular germ cell cancer</article-title><source>Expert Opin. Pharm.</source><year>2019</year><volume>20</volume><fpage>837</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1080/14656566.2019.1583745</pub-id></element-citation></ref><ref id="B58-molecules-25-00183"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komericki</surname><given-names>P.</given-names></name><name><surname>Akkilic-Materna</surname><given-names>M.</given-names></name><name><surname>Strimitzer</surname><given-names>T.</given-names></name><name><surname>Aberer</surname><given-names>W.</given-names></name></person-group><article-title>Efficacy and Safety of Imiquimod Versus Podophyllotoxin in the Treatment of Anogenital Warts</article-title><source>Sex. Transm. Dis.</source><year>2011</year><volume>38</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.1097/OLQ.0b013e3181f68ebb</pub-id></element-citation></ref><ref id="B59-molecules-25-00183"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Z.-J.</given-names></name><name><surname>Lu</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>J.-J.</given-names></name><name><surname>Wang</surname><given-names>X.-X.</given-names></name><name><surname>Su</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name></person-group><article-title>Lariciresinol induces apoptosis in HepG2 cells via mitochondrial-mediated apoptosis pathway</article-title><source>Eur. J. Pharm.</source><year>2018</year><volume>821</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2017.12.027</pub-id></element-citation></ref><ref id="B60-molecules-25-00183"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>D.</given-names></name><name><surname>Wu</surname><given-names>T.Y.</given-names></name><name><surname>Guan</surname><given-names>Y.Q.</given-names></name><name><surname>Ma</surname><given-names>G.X.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>L.L.</given-names></name></person-group><article-title>Chemical constituents from roots of <italic>Stelleropsis tianschanica</italic></article-title><source>China J. Chin. Mater. Med.</source><year>2017</year><volume>42</volume><fpage>3379</fpage><lpage>3384</lpage></element-citation></ref><ref id="B61-molecules-25-00183"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bajpai</surname><given-names>V.K.</given-names></name><name><surname>Shukla</surname><given-names>S.</given-names></name><name><surname>Paek</surname><given-names>W.K.</given-names></name><name><surname>Lim</surname><given-names>J.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Na</surname><given-names>M.K.</given-names></name></person-group><article-title>Efficacy of (+)-Lariciresinol to Control Bacterial Growth of Staphylococcus aureus and Escherichia coli O157:H7</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>804</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.00804</pub-id><?supplied-pmid 28515721?><pub-id pub-id-type="pmid">28515721</pub-id></element-citation></ref><ref id="B62-molecules-25-00183"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>Q.Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Jiang</surname><given-names>B.</given-names></name><name><surname>Zhong</surname><given-names>Z.</given-names></name></person-group><article-title>Lariciresinol-4-<italic>O</italic>-beta-<sc>d</sc>-glucopyranoside from the root of <italic>Isatis indigotica</italic> inhibits influenza A virus-induced pro-inflammatory response</article-title><source>J. Ethnopharmacol.</source><year>2015</year><volume>174</volume><fpage>379</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2015.08.037</pub-id><?supplied-pmid 26320688?><pub-id pub-id-type="pmid">26320688</pub-id></element-citation></ref><ref id="B63-molecules-25-00183"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Liang</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Jiang</surname><given-names>Z.</given-names></name></person-group><article-title>Transcriptome profiling of influenza A virus-infected lung epithelial (A549) cells with lariciresinol-4-beta-D-glucopyranoside treatment</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0173058</elocation-id><pub-id pub-id-type="pmid">28273165</pub-id></element-citation></ref><ref id="B64-molecules-25-00183"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z.L.</given-names></name><name><surname>Liu</surname><given-names>Y.Q.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Tian</surname><given-names>X.</given-names></name></person-group><article-title>The phenylpropanoids of Aster flaccidus</article-title><source>Fitoterapia</source><year>2010</year><volume>81</volume><fpage>140</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2009.08.004</pub-id><?supplied-pmid 19686819?><pub-id pub-id-type="pmid">19686819</pub-id></element-citation></ref><ref id="B65-molecules-25-00183"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>L.</given-names></name><name><surname>Guo</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Jiang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name></person-group><article-title>Isatindolignanoside A, a glucosidic indole-lignan conjugate from an aqueous extract of the <italic>Isatis indigotica</italic> roots</article-title><source>Chin. Chem. Lett.</source><year>2018</year><volume>29</volume><fpage>1257</fpage><lpage>1260</lpage><pub-id pub-id-type="doi">10.1016/j.cclet.2017.12.001</pub-id></element-citation></ref><ref id="B66-molecules-25-00183"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Zhong</surname><given-names>N.</given-names></name></person-group><article-title>Antiviral activity of <italic>Isatis indigotica</italic> root-derived clemastanin B against human and avian influenza A and B viruses in vitro</article-title><source>Int. J. Mol. Med.</source><year>2013</year><volume>31</volume><fpage>867</fpage><lpage>873</lpage><pub-id pub-id-type="doi">10.3892/ijmm.2013.1274</pub-id><pub-id pub-id-type="pmid">23403777</pub-id></element-citation></ref><ref id="B67-molecules-25-00183"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanhchaksai</surname><given-names>K.</given-names></name><name><surname>Kodchakorn</surname><given-names>K.</given-names></name><name><surname>Pothacharoen</surname><given-names>P.</given-names></name><name><surname>Kongtawelert</surname><given-names>P.</given-names></name></person-group><article-title>Effect of sesamin against cytokine production from influenza type A H1N1-induced peripheral blood mononuclear cells: Computational and experimental studies</article-title><source>Vitr. Cell Dev. Biol. Anim.</source><year>2016</year><volume>52</volume><fpage>107</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1007/s11626-015-9950-7</pub-id></element-citation></ref><ref id="B68-molecules-25-00183"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>R.</given-names></name><name><surname>Ci</surname><given-names>X.-X.</given-names></name><name><surname>Li</surname><given-names>H.-Z.</given-names></name><name><surname>Luo</surname><given-names>G.-J.</given-names></name><name><surname>Li</surname><given-names>R.-T.</given-names></name><name><surname>Deng</surname><given-names>X.-M.</given-names></name></person-group><article-title>New Dibenzocyclooctadiene Lignans from Schisandra sphenanthera and Their Proinflammatory Cytokine Inhibitory Activities</article-title><source>Z. F&#x000fc;r Nat. B</source><year>2014</year><volume>65</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1515/znb-2010-0201</pub-id></element-citation></ref><ref id="B69-molecules-25-00183"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szopa</surname><given-names>A.</given-names></name><name><surname>Barna&#x0015b;</surname><given-names>M.</given-names></name><name><surname>Ekiert</surname><given-names>H.</given-names></name></person-group><article-title>Phytochemical studies and biological activity of three Chinese Schisandra species (Schisandra sphenanthera, Schisandra henryi and Schisandra rubriflora): Current findings and future applications</article-title><source>Phytochem. Rev.</source><year>2018</year><volume>18</volume><fpage>109</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1007/s11101-018-9582-0</pub-id></element-citation></ref><ref id="B70-molecules-25-00183"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Checker</surname><given-names>R.</given-names></name><name><surname>Patwardhan</surname><given-names>R.</given-names></name><name><surname>Sharma</surname><given-names>D.</given-names></name><name><surname>Menon</surname><given-names>J.</given-names></name><name><surname>Thoh</surname><given-names>M.</given-names></name><name><surname>Bhilwade</surname><given-names>H.N.</given-names></name><name><surname>Konishi</surname><given-names>T.</given-names></name><name><surname>Sandur</surname><given-names>S.K.</given-names></name></person-group><article-title>Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-kappaB</article-title><source>Free Radic. Biol. Med.</source><year>2012</year><volume>53</volume><fpage>1421</fpage><lpage>1430</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.08.006</pub-id><pub-id pub-id-type="pmid">22917978</pub-id></element-citation></ref><ref id="B71-molecules-25-00183"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S.Y.</given-names></name><name><surname>Park</surname><given-names>S.J.</given-names></name><name><surname>Park</surname><given-names>T.G.</given-names></name><name><surname>Rajasekar</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>S.-J.</given-names></name><name><surname>Choi</surname><given-names>Y.W.</given-names></name></person-group><article-title>Schizandrin C exerts anti-neuroinflammatory effects by upregulating phase II detoxifying/antioxidant enzymes in microglia</article-title><source>Int. Immunopharmacol.</source><year>2013</year><volume>17</volume><fpage>12</fpage><pub-id pub-id-type="doi">10.1016/j.intimp.2013.06.032</pub-id><?supplied-pmid 23859871?><pub-id pub-id-type="pmid">23859871</pub-id></element-citation></ref><ref id="B72-molecules-25-00183"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szopa</surname><given-names>A.</given-names></name><name><surname>Ekiert</surname><given-names>R.</given-names></name><name><surname>Ekiert</surname><given-names>H.</given-names></name></person-group><article-title>Current knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: A review on the bioactive components, pharmacological properties, analytical and biotechnological studies</article-title><source>Phytochem. Rev.</source><year>2017</year><volume>16</volume><fpage>195</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1007/s11101-016-9470-4</pub-id><?supplied-pmid 28424569?><pub-id pub-id-type="pmid">28424569</pub-id></element-citation></ref><ref id="B73-molecules-25-00183"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Lai</surname><given-names>H.</given-names></name><name><surname>Jia</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Qi</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Comprehensive chemical analysis of Schisandra chinensis by HPLC-DAD-MS combined with chemometrics</article-title><source>Phytomed. Int. J. Phytother. Phytopharm.</source><year>2013</year><volume>20</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.1016/j.phymed.2013.05.001</pub-id><?supplied-pmid 23880331?><pub-id pub-id-type="pmid">23880331</pub-id></element-citation></ref><ref id="B74-molecules-25-00183"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J.-S.</given-names></name><name><surname>Wu</surname><given-names>Y.-H.</given-names></name><name><surname>Tseng</surname><given-names>C.-K.</given-names></name><name><surname>Lin</surname><given-names>C.-K.</given-names></name><name><surname>Hsu</surname><given-names>Y.-C.</given-names></name><name><surname>Chen</surname><given-names>Y.-H.</given-names></name><name><surname>Lee</surname><given-names>J.-C.</given-names></name></person-group><article-title>Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>45171</fpage><pub-id pub-id-type="doi">10.1038/srep45171</pub-id><?supplied-pmid 28338050?><pub-id pub-id-type="pmid">28338050</pub-id></element-citation></ref><ref id="B75-molecules-25-00183"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Grandi</surname><given-names>N.</given-names></name><name><surname>Del Vecchio</surname><given-names>C.</given-names></name><name><surname>Mandas</surname><given-names>D.</given-names></name><name><surname>Corona</surname><given-names>A.</given-names></name><name><surname>Piano</surname><given-names>D.</given-names></name><name><surname>Esposito</surname><given-names>F.</given-names></name><name><surname>Parolin</surname><given-names>C.</given-names></name><name><surname>Tramontano</surname><given-names>E.</given-names></name></person-group><article-title>From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors</article-title><source>J. Microbiol.</source><year>2015</year><volume>53</volume><fpage>6</fpage><pub-id pub-id-type="doi">10.1007/s12275-015-4652-0</pub-id><?supplied-pmid 25740376?><pub-id pub-id-type="pmid">25557476</pub-id></element-citation></ref><ref id="B76-molecules-25-00183"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>G.</given-names></name></person-group><article-title>Bicyclol: A Novel Drug for Treating Chronic Viral Hepatitis B and C</article-title><source>Med. Chem.</source><year>2009</year><volume>5</volume><fpage>29</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.2174/157340609787049316</pub-id><pub-id pub-id-type="pmid">19149648</pub-id></element-citation></ref><ref id="B77-molecules-25-00183"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T.</given-names></name></person-group><article-title>New drugs derived from medicinal plants</article-title><source>Th&#x000e9;rapie</source><year>2016</year><volume>57</volume><fpage>14</fpage></element-citation></ref><ref id="B78-molecules-25-00183"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Bai</surname><given-names>X.</given-names></name></person-group><article-title>Comparison of bicyclol therapy for patients with genotype B and C of hepatitis B virus</article-title><source>Chin. J. Exp. Clin. Virol.</source><year>2007</year><volume>21</volume><fpage>3</fpage></element-citation></ref><ref id="B79-molecules-25-00183"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>M.-H.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Xue</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Cheng</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Lv</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication</article-title><source>Acta Pharm. Sin. B</source><year>2019</year><volume>9</volume><fpage>769</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1016/j.apsb.2019.01.013</pub-id><pub-id pub-id-type="pmid">31384537</pub-id></element-citation></ref><ref id="B80-molecules-25-00183"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Chai</surname><given-names>X.</given-names></name></person-group><article-title>Protective effect of bicyclol against pulmonary fibrosis via regulation of microRNA5 in rats</article-title><source>J. Cell. Biochem.</source><year>2019</year><volume>121</volume><fpage>651</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1002/jcb.29310</pub-id><pub-id pub-id-type="pmid">31407409</pub-id></element-citation></ref><ref id="B81-molecules-25-00183"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>R.R.</given-names></name><name><surname>Xiao</surname><given-names>W.L.</given-names></name><name><surname>Yang</surname><given-names>L.M.</given-names></name><name><surname>Wang</surname><given-names>R.R.</given-names></name><name><surname>Sun</surname><given-names>H.D.</given-names></name><name><surname>Liu</surname><given-names>N.F.</given-names></name><name><surname>Zheng</surname><given-names>Y.T.</given-names></name></person-group><article-title>The Isolation of Rubrifloralignan A and Its Anti-HIV-1 Activities</article-title><source>Chin. J. Nat. Med.</source><year>2006</year><volume>4</volume><fpage>40</fpage><lpage>44</lpage></element-citation></ref><ref id="B82-molecules-25-00183"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Kilgore</surname><given-names>N.</given-names></name><name><surname>Lee</surname><given-names>K.-H.</given-names></name><name><surname>Chen</surname><given-names>D.-F.</given-names></name></person-group><article-title>Rubrisandrins A and B, Lignans and Related Anti-HIV Compounds from Schisandra rubriflora</article-title><source>J. Nat. Prod.</source><year>2006</year><volume>69</volume><fpage>1697</fpage><lpage>1701</lpage><pub-id pub-id-type="doi">10.1021/np060239e</pub-id><?supplied-pmid 17190445?><pub-id pub-id-type="pmid">17190445</pub-id></element-citation></ref><ref id="B83-molecules-25-00183"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujihashi</surname><given-names>T.</given-names></name><name><surname>Hara</surname><given-names>H.</given-names></name><name><surname>Sakata</surname><given-names>T.</given-names></name><name><surname>Mori</surname><given-names>K.</given-names></name><name><surname>Higuchi</surname><given-names>H.</given-names></name><name><surname>Tanaka</surname><given-names>A.</given-names></name><name><surname>Kaji</surname><given-names>H.</given-names></name><name><surname>Kaji</surname><given-names>A.</given-names></name></person-group><article-title>Anti-human immunodeficiency virus (HIV) activities of halogenated gomisin J derivatives, new nonnucleoside inhibitors of HIV type 1 reverse transcriptase</article-title><source>Antimicrob. Agents Chemother.</source><year>1995</year><volume>39</volume><fpage>2000</fpage><lpage>2007</lpage><pub-id pub-id-type="doi">10.1128/AAC.39.9.2000</pub-id><?supplied-pmid 8540706?><pub-id pub-id-type="pmid">8540706</pub-id></element-citation></ref><ref id="B84-molecules-25-00183"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Federico</surname><given-names>A.</given-names></name><name><surname>Dallio</surname><given-names>M.</given-names></name><name><surname>Loguercio</surname><given-names>C.</given-names></name></person-group><article-title>Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>191</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22020191</pub-id><?supplied-pmid 28125040?><pub-id pub-id-type="pmid">28125040</pub-id></element-citation></ref><ref id="B85-molecules-25-00183"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strader</surname><given-names>D.B.</given-names></name><name><surname>Bacon</surname><given-names>B.R.</given-names></name><name><surname>Lindsay</surname><given-names>K.L.</given-names></name><name><surname>La Brecque</surname><given-names>D.R.</given-names></name><name><surname>Morgan</surname><given-names>T.</given-names></name><name><surname>Wright</surname><given-names>E.C.</given-names></name><name><surname>Seeffff</surname><given-names>L.B.</given-names></name></person-group><article-title>Use of complementary and alternative medicine in patients with liver disease</article-title><source>Am. J. Gastroenterol.</source><year>2002</year><volume>97</volume><fpage>7</fpage><pub-id pub-id-type="doi">10.1111/j.1572-0241.2002.05993.x</pub-id><?supplied-pmid 12358262?><pub-id pub-id-type="pmid">12358262</pub-id></element-citation></ref><ref id="B86-molecules-25-00183"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C.-H.</given-names></name><name><surname>Jassey</surname><given-names>A.</given-names></name><name><surname>Hsu</surname><given-names>H.-Y.</given-names></name><name><surname>Lin</surname><given-names>L.-Z.</given-names></name></person-group><article-title>Antiviral Activities of Silymarin and Derivatives</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>1552</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24081552</pub-id></element-citation></ref><ref id="B87-molecules-25-00183"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagoner</surname><given-names>J.</given-names></name><name><surname>Negash</surname><given-names>A.</given-names></name><name><surname>Kane</surname><given-names>O.J.</given-names></name><name><surname>Martinez</surname><given-names>L.E.</given-names></name><name><surname>Nahmias</surname><given-names>Y.</given-names></name><name><surname>Bourne</surname><given-names>N.</given-names></name><name><surname>Owen</surname><given-names>D.M.</given-names></name><name><surname>Grove</surname><given-names>J.</given-names></name><name><surname>Brimacombe</surname><given-names>C.</given-names></name><name><surname>McKeating</surname><given-names>J.A.</given-names></name><etal/></person-group><article-title>Multiple effects of silymarin on the hepatitis C virus lifecycle</article-title><source>Hepatology</source><year>2010</year><volume>51</volume><fpage>1912</fpage><lpage>1921</lpage><pub-id pub-id-type="doi">10.1002/hep.23587</pub-id><pub-id pub-id-type="pmid">20512985</pub-id></element-citation></ref><ref id="B88-molecules-25-00183"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DebRoy</surname><given-names>S.</given-names></name><name><surname>Hiraga</surname><given-names>N.</given-names></name><name><surname>Imamura</surname><given-names>M.</given-names></name><name><surname>Hayes</surname><given-names>C.N.</given-names></name><name><surname>Akamatsu</surname><given-names>S.</given-names></name><name><surname>Canini</surname><given-names>L.</given-names></name><name><surname>Perelson</surname><given-names>A.S.</given-names></name><name><surname>Pohl</surname><given-names>R.T.</given-names></name><name><surname>Persiani</surname><given-names>S.</given-names></name><name><surname>Uprichard</surname><given-names>S.L.</given-names></name></person-group><article-title>Hepatitis C virus dynamics and cellular gene expression in uPA-SCID chimeric mice with humanized livers during intravenous silibinin monotherapy</article-title><source>J. Viral Hepat.</source><year>2016</year><volume>23</volume><fpage>708</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1111/jvh.12551</pub-id><pub-id pub-id-type="pmid">27272497</pub-id></element-citation></ref><ref id="B89-molecules-25-00183"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>J.H.</given-names></name><name><surname>Choi</surname><given-names>H.J.</given-names></name></person-group><article-title>Silymarin efficacy against influenza a virus replication</article-title><source>Phytomedicine</source><year>2011</year><volume>18</volume><fpage>832</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2011.01.026</pub-id><pub-id pub-id-type="pmid">21377857</pub-id></element-citation></ref><ref id="B90-molecules-25-00183"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Meng</surname><given-names>A.-P.</given-names></name><name><surname>Guan</surname><given-names>X.-L.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Deng</surname><given-names>S.-P.</given-names></name><name><surname>Su</surname><given-names>X.-J.</given-names></name><name><surname>Yang</surname><given-names>R.-Y.</given-names></name></person-group><article-title>Anti-hepatitis B virus lignans from the root of Streblus asper</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2013</year><volume>23</volume><fpage>2238</fpage><lpage>2244</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2013.01.046</pub-id><pub-id pub-id-type="pmid">23434030</pub-id></element-citation></ref><ref id="B91-molecules-25-00183"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Cheng</surname><given-names>X.-H.</given-names></name><name><surname>Wang</surname><given-names>H.-G.</given-names></name><name><surname>Yu</surname><given-names>D.-Y.</given-names></name><name><surname>Feng</surname><given-names>B.-M.</given-names></name></person-group><article-title>Advances on the secolignans compounds in natural products</article-title><source>J. Shenyang Pharm. Univ.</source><year>2014</year><volume>11</volume><fpage>922</fpage><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://en.cnki.com.cn/Article_en/CJFDTotal-SYYD201411019.htm">http://en.cnki.com.cn/Article_en/CJFDTotal-SYYD201411019.htm</ext-link></comment></element-citation></ref><ref id="B92-molecules-25-00183"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>X.</given-names></name><name><surname>Na</surname><given-names>L.</given-names></name><name><surname>Ning</surname><given-names>M.-M.</given-names></name><name><surname>Zhou</surname><given-names>C.-H.</given-names></name><name><surname>Yang</surname><given-names>Q.-R.</given-names></name><name><surname>Wang</surname><given-names>M.W.</given-names></name></person-group><article-title>Bioactive Compounds from Peperomia pellucida</article-title><source>J. Nat. Prod.</source><year>2006</year><volume>69</volume><fpage>247</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">16499324</pub-id></element-citation></ref><ref id="B93-molecules-25-00183"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>B.M.</given-names></name><name><surname>Qin</surname><given-names>H.H.</given-names></name><name><surname>Wang</surname><given-names>H.G.</given-names></name><name><surname>Shi</surname><given-names>L.Y.</given-names></name><name><surname>Yu</surname><given-names>D.Y.</given-names></name><name><surname>Ji</surname><given-names>B.Q.</given-names></name><name><surname>Zhao</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>Y.Q.</given-names></name></person-group><article-title>Three new secolignan glycosides from Urtica fissa E. Pritz</article-title><source>J. Nat. Med.</source><year>2012</year><volume>66</volume><fpage>562</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1007/s11418-011-0615-x</pub-id><?supplied-pmid 22124934?><pub-id pub-id-type="pmid">22124934</pub-id></element-citation></ref><ref id="B94-molecules-25-00183"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>W.-S.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Zheng</surname><given-names>X.-K.</given-names></name><name><surname>Wang</surname><given-names>Y.-Z.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name></person-group><article-title>Two new secolignans from Selaginella sinensis (Desv.) Spring</article-title><source>J. Asian Nat. Prod. Res.</source><year>2009</year><volume>11</volume><fpage>658</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1080/10286020902971011</pub-id><?supplied-pmid 20183303?><pub-id pub-id-type="pmid">20183303</pub-id></element-citation></ref><ref id="B95-molecules-25-00183"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>M.-J.</given-names></name><name><surname>Lee</surname><given-names>S.-J.</given-names></name><name><surname>Chang</surname><given-names>Y.-Y.</given-names></name><name><surname>Wu</surname><given-names>S.-H.</given-names></name><name><surname>Tsai</surname><given-names>I.-L.</given-names></name><name><surname>Jayaprakasam</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>I.-S.</given-names></name></person-group><article-title>Chemical and cytotoxic constituents from Peperomia sui</article-title><source>Phytochemistry</source><year>2003</year><volume>63</volume><fpage>603</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(03)00183-3</pub-id><pub-id pub-id-type="pmid">12809722</pub-id></element-citation></ref><ref id="B96-molecules-25-00183"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsutsui</surname><given-names>C.</given-names></name><name><surname>Yamada</surname><given-names>Y.</given-names></name><name><surname>Ando</surname><given-names>M.</given-names></name><name><surname>Toyama</surname><given-names>D.</given-names></name><name><surname>Wu</surname><given-names>J.L.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Taketani</surname><given-names>S.</given-names></name><name><surname>Kataoka</surname><given-names>T.</given-names></name></person-group><article-title>Peperomins as anti-inflammatory agents that inhibit the NF-kappaB signaling pathway</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2009</year><volume>19</volume><fpage>4084</fpage><lpage>4087</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2009.06.029</pub-id><?supplied-pmid 19559609?><pub-id pub-id-type="pmid">19559609</pub-id></element-citation></ref><ref id="B97-molecules-25-00183"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Govindachari</surname><given-names>T.R.</given-names></name><name><surname>Kumari</surname><given-names>G.N.K.</given-names></name><name><surname>Partho</surname><given-names>P.D.</given-names></name></person-group><article-title>Two secolignans from Peperomia dindigulensis</article-title><source>Phytochemistry</source><year>1998</year><volume>49</volume><fpage>2129</fpage><lpage>2131</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(98)00393-8</pub-id></element-citation></ref><ref id="B98-molecules-25-00183"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name></person-group><article-title>Secolignans with Antiangiogenic Activities from Peperomia dindygulensis</article-title><source>Chem. Biodivers.</source><year>2011</year><volume>8</volume><fpage>862</fpage><lpage>870</lpage><pub-id pub-id-type="doi">10.1002/cbdv.201000123</pub-id><pub-id pub-id-type="pmid">21560234</pub-id></element-citation></ref><ref id="B99-molecules-25-00183"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G.-L.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>Y.-H.</given-names></name><name><surname>Zheng</surname><given-names>Y.-T.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>M.-W.</given-names></name></person-group><article-title>Bioactive lignans from Peperomia heyneana</article-title><source>J. Nat. Prod.</source><year>2007</year><volume>70</volume><fpage>662</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1021/np0605236</pub-id><pub-id pub-id-type="pmid">17291043</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-25-00183-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The monomers and this classification of lignans.</p></caption><graphic xlink:href="molecules-25-00183-g001"/></fig><fig id="molecules-25-00183-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Relationships between different classical lignans. It depicts the basic mother nucleus structure of different subtypes of classical lignans, the main structural feature of this subclass is the &#x003b2;-&#x003b2;&#x02032; linkage. Dibenzylbutane (central position) is the basic structure of classical lignan, other subtypes of lignans derive from this structure with different chemical reactions.</p></caption><graphic xlink:href="molecules-25-00183-g002"/></fig><fig id="molecules-25-00183-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Structures of dibenzylbutanes and corresponding compounds.</p></caption><graphic xlink:href="molecules-25-00183-g003"/></fig><fig id="molecules-25-00183-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Structures of dibenzylbutyrolactone and corresponding compounds.</p></caption><graphic xlink:href="molecules-25-00183-g004"/></fig><fig id="molecules-25-00183-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Structures of arylnaphthalene/aryltetralin and corresponding compounds.</p></caption><graphic xlink:href="molecules-25-00183-g005"/></fig><fig id="molecules-25-00183-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Structures of substituted tetrahydrofurans and corresponding compounds.</p></caption><graphic xlink:href="molecules-25-00183-g006"/></fig><fig id="molecules-25-00183-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Structures of 2,6-diarylfurofurans and corresponding compounds.</p></caption><graphic xlink:href="molecules-25-00183-g007"/></fig><fig id="molecules-25-00183-f008" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Structures of dibenzocyclooctene and corresponding compounds.</p></caption><graphic xlink:href="molecules-25-00183-g008"/></fig><fig id="molecules-25-00183-f009" orientation="portrait" position="float"><label>Figure 9</label><caption><p>Bicyclol as an anti-HBV drug [<xref rid="B76-molecules-25-00183" ref-type="bibr">76</xref>]. Schizandrin C was isolated from <italic>F. Schizandrae</italic> and verified as the most active compound in protection against liver injury in mice. DDB (Dimethyl dicarboxylate biphenyl) as an analog of schizandrin C has been widely used for the improvement of the abnormal liver function of CHB hepatitis in China. Bicyclol as a novel substitute for DDB was found to be more effective in protection against liver injury and was also showed to inhibit hepatitis virus replication in vitro and in vivo.</p></caption><graphic xlink:href="molecules-25-00183-g009"/></fig><fig id="molecules-25-00183-f010" orientation="portrait" position="float"><label>Figure 10</label><caption><p>Structures of some neolignan compounds.</p></caption><graphic xlink:href="molecules-25-00183-g010"/></fig><table-wrap id="molecules-25-00183-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-00183-t001_Table 1</object-id><label>Table 1</label><caption><p>The antiviral activities of lignans and their derivatives from plants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Subclass</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cpd</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">From Plants</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Organs</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Virus(es)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IC<sub>50</sub> (&#x003bc;M)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CC<sub>50</sub> (&#x003bc;M)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Status</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MOA/Targets</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Refs</th></tr></thead><tbody><tr><td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Dibenzylbutanes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Niranthin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Phyllanthus niruri</italic> L. (Euphorbiaceae)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Whole plants</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HBV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.6~25.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">369.9 In HepG 2.2.15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro<break/>In Vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibits DHBV DNA replication and HBV antigen expression.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B12-molecules-25-00183" ref-type="bibr">12</xref>,<xref rid="B16-molecules-25-00183" ref-type="bibr">16</xref>]</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NDGA</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Larrea tridentate</italic> (Zygophyllaceae)</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Leaves (resin)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DENV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">targets genome replication and viral assembly</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B22-molecules-25-00183" ref-type="bibr">22</xref>,<xref rid="B23-molecules-25-00183" ref-type="bibr">23</xref>,<xref rid="B24-molecules-25-00183" ref-type="bibr">24</xref>,<xref rid="B25-molecules-25-00183" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70 in Huh7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NDGA-mediated alterations of host lipid metabolism, LD morphology, and VLDL transport affect HCV proliferation</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WNV/ZIKV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.9/9.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">162.1 in Vero</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WNV: disturb the lipid metabolism probably by interfering with the sterol regulatory element binding proteins (SREBP) pathway</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IAV</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">In Vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">suppresses replication of IAV and induction of cytokines, trypsin, and MMP-9, with improved animal survival</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">TMP</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Larrea tridentata</italic> (Zygophyllaceae)</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Leaves (resin)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WNV/ZIKV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.3/5.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1071.0 in Vero</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">impaires viral replication</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B24-molecules-25-00183" ref-type="bibr">24</xref>,<xref rid="B26-molecules-25-00183" ref-type="bibr">26</xref>,<xref rid="B27-molecules-25-00183" ref-type="bibr">27</xref>,<xref rid="B28-molecules-25-00183" ref-type="bibr">28</xref>,<xref rid="B29-molecules-25-00183" ref-type="bibr">29</xref>,<xref rid="B30-molecules-25-00183" ref-type="bibr">30</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">poxvirus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">prevents the efficient spread of virus particles from cell to cell</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">160 in Vero</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">TMP inhibits both these viruses replication by blocking the binding of the host cell transcription factor, Sp1, to viral promoters.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPV</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">In Clinical</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">selectively interferes with HPV viral genes E6/E7 with Sp1dependent promoters, and induces apoptosis by inactivation of the CDC2/cyclin B complex (maturation promoting factor) and production and phosphorylation of survivin</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Secoisolariciresinol dimethyleTher acetate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Justicia procumbens</italic> (Acanthaceae)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Air-dried aerial parts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">waiting for the deeper research</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B31-molecules-25-00183" ref-type="bibr">31</xref>]</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Dibenzyltyrolactones</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">ATG</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Arctium lappa</italic> L. (Compositae)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Whole plants</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IAV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro<break/>In Vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">induce the production of interferon</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B32-molecules-25-00183" ref-type="bibr">32</xref>,<xref rid="B33-molecules-25-00183" ref-type="bibr">33</xref>,<xref rid="B34-molecules-25-00183" ref-type="bibr">34</xref>,<xref rid="B35-molecules-25-00183" ref-type="bibr">35</xref>,<xref rid="B36-molecules-25-00183" ref-type="bibr">36</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibit the expression of protein P17 and P24 of the HIV-1 virus</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yatein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Chamaecyparis obtuse</italic> (Cupressaceae)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dried leaves</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSV-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30.6 &#x000b1; 5.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibiting HSV-1 alpha gene expression, including expression of the ICP0 and ICP4 genes, and by arresting HSV-1 DNA synthesis and structural protein expression in HeLa cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B37-molecules-25-00183" ref-type="bibr">37</xref>,<xref rid="B38-molecules-25-00183" ref-type="bibr">38</xref>]</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Hinokinin</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Chamecyparis obtusa</italic> (Cupressaceae)</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Woods</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HBV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">waiting for the deeper research</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B12-molecules-25-00183" ref-type="bibr">12</xref>,<xref rid="B45-molecules-25-00183" ref-type="bibr">45</xref>,<xref rid="B46-molecules-25-00183" ref-type="bibr">46</xref>,<xref rid="B47-molecules-25-00183" ref-type="bibr">47</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">527 in H9</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SARS-CoV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;750 in Vero</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCMV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">115 in A549</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Arylnaphthalenes</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Diphyllin</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">genus <italic>Haplophyllum</italic> (Rutaceae)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Epigeal part</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ZIKV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.06</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.48 in MDCK</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">vacuolar ATPase (V-ATPase) inhibitors</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B48-molecules-25-00183" ref-type="bibr">48</xref>,<xref rid="B49-molecules-25-00183" ref-type="bibr">49</xref>,<xref rid="B50-molecules-25-00183" ref-type="bibr">50</xref>,<xref rid="B51-molecules-25-00183" ref-type="bibr">51</xref>,<xref rid="B52-molecules-25-00183" ref-type="bibr">52</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IAV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1&#x02013;0.6 in different strains</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.1 in A549</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibit endosomal acidification, thus interfering with downstream virus replication</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">DGP</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Justicia gendarussa</italic> (Acanthaceae)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Stems and leaves</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ZIKV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01&#x02013;0.07</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15&#x02013;32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro<break/>In Vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">prevented the acidification of endosomal/lysosomal compartments in target cells, thus inhibiting ZIKV fusion with cellular membranes and infection.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B51-molecules-25-00183" ref-type="bibr">51</xref>,<xref rid="B53-molecules-25-00183" ref-type="bibr">53</xref>,<xref rid="B54-molecules-25-00183" ref-type="bibr">54</xref>,<xref rid="B55-molecules-25-00183" ref-type="bibr">55</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15&#x02013;21 nM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 reverse transcription</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aryltetralins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Dysosmae Verspiellis &#x00026; Podophyllum peltatum</italic> (Berberidaceae)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Roots and stems</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Papilloma virus</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Launched in China</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">waiting for the deeper research</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B3-molecules-25-00183" ref-type="bibr">3</xref>,<xref rid="B11-molecules-25-00183" ref-type="bibr">11</xref>,<xref rid="B56-molecules-25-00183" ref-type="bibr">56</xref>,<xref rid="B57-molecules-25-00183" ref-type="bibr">57</xref>,<xref rid="B58-molecules-25-00183" ref-type="bibr">58</xref>]</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Substituted tetrahydrofurans</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">lariciresinol-4-<italic>O</italic>-&#x003b2;-<sc>d</sc>-glucopyranoside</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Isatis indigotica</italic> Fort (Cruciferae)</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Roots</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IAV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 &#x003bc;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;200 &#x003bc;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pharmacological actions on the immune system, signal transduction, cell cycle, and metabolism</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B62-molecules-25-00183" ref-type="bibr">62</xref>,<xref rid="B63-molecules-25-00183" ref-type="bibr">63</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<italic>7&#x02032;R</italic>, <italic>8S</italic>)-9&#x02032;-lariciresinol-(&#x003b1;-methyl)-butanoate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.66 mM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.67mM in C8166</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B64-molecules-25-00183" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isatindolignanoside A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CVB3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">waiting for the deeper research</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B65-molecules-25-00183" ref-type="bibr">65</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clemastanin B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IAV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.087&#x02013;0.72 mg/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.2&#x02013;7.5 mg/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">targets viral endocytosis, uncoating or RNP export from the nucleus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-molecules-25-00183" ref-type="bibr">66</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">2,6-diarylfurofurans</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phillygenin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Fructus Forsythiae</italic> (Oleaceae)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fruits</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IAV</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">In Vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">reduce inflammation caused by IAV.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B57-molecules-25-00183" ref-type="bibr">57</xref>,<xref rid="B58-molecules-25-00183" ref-type="bibr">58</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sesamin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Sesamum indicum</italic> (Pedaliaceae)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Seeds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inflammatory cytokines induced by H1N1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anti-inflammatory cytokines in human PBMCs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B67-molecules-25-00183" ref-type="bibr">67</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dibenzocyclooctene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bicyclol</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Analogue of schizandrin C from <italic>Fructus Schiznadrae</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HBV</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Launched in China</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibit virus replication in patients infected with HBV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B76-molecules-25-00183" ref-type="bibr">76</xref>,<xref rid="B77-molecules-25-00183" ref-type="bibr">77</xref>,<xref rid="B78-molecules-25-00183" ref-type="bibr">78</xref>,<xref rid="B79-molecules-25-00183" ref-type="bibr">79</xref>,<xref rid="B80-molecules-25-00183" ref-type="bibr">80</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro/Vivo/Clinical</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">modulation of cytotoxic T lymphocytes<break/>up-regulating the host restrictive factor (GLTP) for HCV replication, and causing spontaneous restriction of HCV replication</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rubrifloralignan A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Schisandra rubriflora</italic> (Schisandraceae)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fruits</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.46</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">123.35</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibit the early stage of HIV-1 replication</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B81-molecules-25-00183" ref-type="bibr">81</xref>,<xref rid="B82-molecules-25-00183" ref-type="bibr">82</xref>,<xref rid="B83-molecules-25-00183" ref-type="bibr">83</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">1,4-Benzodioxane lignans</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Silymarin</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Silybum marianum</italic> (Compositae)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Seeds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCV</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">In Clinical</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">blocked HCV production, increased anti-inflammatory, anti-proliferative gene expressions without affecting serum albumin levels</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B84-molecules-25-00183" ref-type="bibr">84</xref>,<xref rid="B85-molecules-25-00183" ref-type="bibr">85</xref>,<xref rid="B86-molecules-25-00183" ref-type="bibr">86</xref>,<xref rid="B87-molecules-25-00183" ref-type="bibr">87</xref>,<xref rid="B88-molecules-25-00183" ref-type="bibr">88</xref>,<xref rid="B89-molecules-25-00183" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IAV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibition of late viral RNA synthesis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dimer of strebluslignanols</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<italic>7&#x02032;R</italic>,<italic>8&#x02032;S</italic>,<italic>7&#x02033;R</italic>,<italic>8&#x02033;S</italic>)-erythro-strebluslignanolG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Streblus asper</italic> (Moraceae)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Roots</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HBV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.67/HBsAg 14.67/HBeAg</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibit the secretion of HBsAg and HBeAg</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B90-molecules-25-00183" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Secolignans</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peperomins A&#x00026;B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Peperomia pellucida</italic> (Piperaceae)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Whole plants</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 IIIB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No data</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">related to the cytotoxicity expressed as CC<sub>50</sub> of compounds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B98-molecules-25-00183" ref-type="bibr">98</xref>,<xref rid="B99-molecules-25-00183" ref-type="bibr">99</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>IC<sub>50</sub>, inhibitory concentration of compound that produces 50% inhibition of virus-induced cytopathic effects; CC<sub>50</sub>, concentration that reduces the growth of target cells by 50%.</p></fn></table-wrap-foot></table-wrap></floats-group></article>